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 During mating males transfer not only sperm, but also protein and other 
substances in their seminal fluid.  The functions of some seminal fluid components have 
been identified and these include aiding in sperm motility and protecting sperm from the 
harsh environment of the female reproductive tract.  However, the function of most 
seminal fluid components are unknown.  In this dissertation, I identify a seminal fluid 
protease, TRY-5, in Caenorhabditis elegans and show that it functions in sperm 
activation, a necessary step in production of functional sperm.
 C. elegans is a nematode that consists of two sexes: males, which produce only 
sperm, and hermaphrodites, which produce both sperm and eggs.  During activation, each 
sperm cell develops a pseudopod, which allows sperm to migrate and fertilize oocytes.  
Male sperm are stored as nonmotile, nonactivated sperm, and little is known about the 
extracellular signals required for their activation.  SWM-1, a protein with two trypsin 
inhibitor-like domains and a secretion signal, was identified as an inhibitor of male sperm 
activation.  Here, I show a trypsin-like serine protease, TRY-5, is an extracellular signal 
for sperm activation necessary for sperm activation in swm-1 mutant males.  While swm-
1 mutant males contain prematurely activated sperm, swm-1 try-5 males contain 
nonactivated sperm.  Despite being a signal for activation, try-5 is not required for male 
fertility, suggesting the existence of additional sperm activation signals.  This alternative 
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signal likely comes from hermaphrodites, since a known hermaphrodite sperm activation 
pathway is required for male sperm activation in the absence of TRY-5. 
 To test whether TRY-5 functions in seminal fluid, I examined the localization of 
TRY-5 protein.  A TRY-5::GFP fusion expressed under a try-5 promoter localized to 
several tissues of the somatic gonad that are involved in the storage and transfer of sperm, 
including the vas deferens and valve region.  I followed TRY-5::GFP localization during 
mating and found that TRY-5::GFP was transferred to hermaphrodites, making TRY-5 a 
likely seminal fluid component.  Transfer occurred in a consistent pattern, suggesting this 
process is well regulated.  Overall, these results suggest that TRY-5 is a protease seminal 
fluid signal of sperm activation. 
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 Infertility, defined as being unable to conceive despite trying for one year, affects 
as many as 24% of couples in the United States (Greenhall and Vessey, 1990).  This 
definition does not consider whether the inability to conceive is due to male factors, 
female factors, or a combination of the two.  However, it has been estimated that 40-60% 
of cases have a male component (reviewed in Niederberger, 2007).  The causes of male 
infertility are poorly understood.  When investigating cases of inability to conceive, 
attention is placed mainly on sperm number, motility, and appearance (World Health 
Organization, 2010).  These factors fail to explain approximately 25% of male infertility 
cases (Lipshultz, 1997).  A better understanding of the other components of transferred 
semen may provide opportunities for treating male infertility.
 Sperm motility is of particular interest in studying fertility.  In internally-
fertilizing animals, sperm must migrate through the female reproductive tract to reach an 
oocyte.  Therefore, improper regulation of motility can negatively impact sperm success.  
For instance, late, reduced, or no motility in sperm can reduce fertility, since fewer or no 
sperm would be able to reach an oocyte (World Health Organization, 2010).  Since 
motility plays such a key role in male fertility, much study has been dedicated to 
understanding how it is regulated. 
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 Mammals and Drosophila share a similar mode of reproduction; both are 
gonochoristic (male-female).  In mammals, including humans, sperm become active in 
the epididymis (reviewed in Gatti et al., 2004), and then become even more active after 
transfer in a process termed hyperactivation (reviewed in Salicioni et al., 2007).  In 
Drosophila, sperm become active within cysts shortly after development (Fabrizio et al., 
1998), but no difference in motility has been observed after transfer (Perotti, 1969).  In 
contrast to mammals and Drosophila, C. elegans is an androdioecious species; it has 
males that produce only sperm and hermaphrodites that produce both sperm and oocytes.   
In this species, within the male, sperm are stored in a nonmotile state, and sperm gain 
motility during mating in a process termed sperm activation (reviewed in L'Hernault, 
2006).  In hermaphrodites, sperm activate within the spermathecae, the sites of sperm 
storage and fertilization.  If sperm do not activate, fertilization does not occur (L'Hernault 
et al., 1988).  In this introduction, I will describe common mechanisms that exist to 
regulate sperm development and motility in mammals, including humans, as well as the 
model organisms Drosophila melanogaster and C. elegans, focusing on seminal fluid 
components. 
 
Changes in motility over time 
 Between species, sperm vary greatly in their appearance and how they generate 
motility.  In humans, other mammals, and Drosophila, a flagellum on the sperm 
generates force to move the cell.  In nematodes, sperm have a significantly different 
appearance from flagellated sperm.  Instead of having a flagellum, they have a 
pseudopod, and C. elegans sperm move by crawling in an amoeboid fashion (reviewed in 
L'Hernault, 2006). 
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 Motility is not constant during a sperm cell’s existence but instead is tightly 
regulated.  In mammals, after the overall sperm structure has developed, sperm move to 
the epididymis.  Within the epididymis, the seminal fluid that surrounds the sperm 
changes significantly.  Here, sperm gain initial motility as they undergo further 
maturation and are stored until mating occurs (reviewed in Sullivan et al., 2005).  The 
signals responsible for this increase in motility are unknown; however, this process has 
been shown to be dependent on cAMP, calcium signaling, and increased levels of protein 
phosphorylation (reviewed in Gatti et al., 2004). 
 Once sperm have been transferred to the female, motility changes again.  Sperm 
become hyperactivated as their tails beat more strongly and form more bends.  In 
mammals, hyperactivation is one step of capacitation, during which sperm gain the ability 
to fertilize an oocyte.  Hyperactivation occurs in the uterus or the oviduct, possibly in 
response to signals from both the oviduct and the egg (reviewed in Suarez, 2008).  While 
it is apparent that extracellular signals regulate mammalian sperm motility, those signals 
remain poorly understood. 
 In Drosophila sperm development occurs differently than in mammals.  Similar to 
mammals, during spermatogenesis, sperm gain the structures necessary for motility and 
sperm begin to move shortly after development, but before mating occurs (Fabrizio et al., 
1998).  However, once sperm are transferred to the female, no further morphological 
changes are observed, either immediately or several days after mating (Perotti, 1969).  
Movement of sperm within the female occurs continuously, with sperm constantly 
moving between the sperm storage organs and the uterus (Yang and Lu, 2011).  While 
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Drosophila sperm motility has been studied on the level of its role in sperm competition, 
less attention has been paid to regulation of motility. 
 During C. elegans sperm activation, many physiological changes occur within 
sperm.  Overall, cell morphology changes from being round to having a pseudopod, 
polarizing the cell in the process.  Membranous organelles fuse with the plasma 
membrane, releasing proteins into the extracellular matrix and introducing new proteins 
to the sperm surface (Washington and Ward, 2006).  Within the pseudopod major sperm 
protein (MSP), the only cytoskeleton protein in sperm, polymerizes, allowing for the 
formation of the pseudopod and for movement to occur (Smith, 2006).  Sperm also gain 
the ability to fertilize oocytes. 
 
Intracellular regulators of sperm motility 
 Since sperm motility in mammals and C. elegans changes as the cells enter 
different tissues, changes in motility are likely to be regulated.  In mammals, a significant 
change to motility occurs during capacitation, during which sperm become 
hyperactivated and become fully competent for fertilization.  Several proteins have been 
found to have a role in regulation of sperm motility.  One such protein is hydrogen 
voltage-gated channel 1 (Hv1), which has roles in proton transport.  Hv1 has been 
implicated in increasing pH levels in human sperm after transfer, but it is not expressed in 
mouse sperm (Lishko et al., 2010).  The increase in intracellular pH is hypothesized to 
open CatSper channels (cation channel, sperm associated), increasing levels of 
intracellular Ca
2+
, which is thought to increase motility (reviewed in Lishko and 
Kirichok, 2010).  pH has been implicated in the process of C. elegans sperm activation; 
as sperm activate, intracellular pH increases (Ward et al., 1983).  No functional relevance 
  5 
 
 
for this increase has been shown.  Another protein that regulates motility in mouse sperm 
and is conserved in humans is A-kinase anchor protein 4 (AKAP4).  This protein 
localizes cyclic AMP dependent kinases.  Mice mutant for Akap4 produce sperm that 
have significantly reduced motility, suggesting that proper regulation of phosphorylation 
is necessary for sperm motility (Miki et al., 2002).  cAMP has also been shown to 
increase sperm motility in a concentration-dependent manner (Gorus et al., 1982; Liu et 
al., 2003).  cAMP has been suggested to stimulate protein kinase A (PKA), which then 
phosphorylates other proteins that signal capacitation (Krapf et al., 2010).  In C. elegans, 
two different kinases have been shown to be necessary for normal sperm activation, spe-8 
(L'Hernault et al., 1988) and spe-6 (Muhlrad and Ward, 2002). These various means of 
signaling capacitation or motility show that this is a tightly regulated process. 
 Several molecules necessary for human sperm motility are also present in 
Drosophila; however their contributions to sperm motility may differ.  cAMP may have 
roles in male fertility.  A deficiency that reduced cAMP phosphodiesterase activity 
resulted in infertile males; however, this deficiency also removed additional genes 
(Kiger, 1977).  Phosphatases also have an indirect role in Drosophila sperm motility.  
Phosphatidylinositol 4,5-bisphosphate (PI4,5P) is necessary for the proper formation of 
flagella, since overexpression of PI4,5P phosphatases result in sperm that do not properly 
form flagella (Wei et al., 2008).  However, no direct relationship between phosphatases 
and motility has been shown.  In addition, Ca
2+
 has been shown to have roles in 
mediating sperm motility, as a loss-of-function cation channel (Pkd2) mutation results in 
sperm that are unable to enter sperm storage organs in the female after transfer (Yang and 
Lu, 2011). 
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 In C. elegans, several regulators of sperm motility have been identified.  Some of 
these components are conserved in mammals, but others are found only in nematodes.  
Activation factors include a group of five genes, termed the spe-8 group, consisting of 
spe-8, -12, -19, -27, and -29.  Most of these genes encode novel proteins, except for spe-
8, which encodes a tyrosine kinase (Geldziler et al., 2005; L'Hernault, 2009; L'Hernault et 
al., 1988; Minniti et al., 1996; Nance et al., 2000; Nance et al., 1999).  Some of the SPE-8 
group proteins have transmembrane domains, suggesting that they are present at the 
surface of the sperm cell.  These genes are a group, since a mutation in any one of these 
genes results in the same phenotype: hermaphrodites that are sterile because their sperm 
do not activate.  Interestingly, mutant males are fully fertile and are capable of rescuing 
hermaphrodite fertility, which suggests that a separate activator might be present in the 
male seminal fluid.  In vitro, wild-type male sperm activates in the presence of Pronase, a 
mixture of proteases.  spe-8 group mutant sperm do not activate in the presence of 
Pronase, although they can be fully activated by triethanolamine (TEA), a weak base that 
also activates sperm in vitro (Shakes and Ward, 1989).  These results suggest that 
proteases may act as a male-derived activation signal.  An additional kinase, spe-6, 
necessary for proper regulation of sperm activation has been identified downstream of the 
spe-8 group.  This gene encodes a casein kinase I.  spe-6 functions during multiple steps 
of sperm development: early in sperm development, spe-6 is necessary for the packaging 
of MSP in sperm (Varkey et al., 1993).  After spermatids develop, spe-6 is required for 
the inhibition of sperm activation, since males with certain alleles of spe-6 contain 
activated sperm (Muhlrad and Ward, 2002).   
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Seminal fluid production 
 Males transfer sperm in a medium termed seminal fluid.  Since seminal fluid 
components change during sperm development (reviewed in Sostaric et al., 2008) or are 
added during sperm transfer, this fluid would be an ideal candidate for containing sperm 
regulators. 
 In mammals, several tissues produce seminal fluid: the vas deferens, the prostate, 
and the seminal vesicles (reviewed in Bronson, 2011).  Seminal fluid from the fruit fly 
Drosophila melanogaster is also produced by several tissues.  These secretory tissues 
include the accessory glands, seminal vesicles, ejaculatory duct, ejaculatory bulb, and 
testes (reviewed in Avila et al., 2011).  As in mammals, some of these tissues modify 
seminal fluid during mating and have roles in maximizing fertility.  
 Much less is known about the source, or even existence, of seminal fluid in C. 
elegans.  The only previously identified seminal fluid protein was PLG-1, a mucin that 
forms a mating plug over the hermaphrodite’s vulva (Hodgkin and Doniach, 1997; 
Palopoli et al., 2008).  plg-1 was shown to be expressed in the vas deferens, a tube 
through which sperm pass during mating.  However, the vas deferens represents only one 
of three tissues that sperm come in contact with after finishing meiosis; the other two are 
the seminal vesicle, the storage site for sperm, and the valve region, a structure that 
regulates the release of sperm during mating (Lints and Hall, 2009). 
 
Seminal fluid regulators of fertility and motility 
 In mice and humans, many components of seminal fluid have been identified.  
Proteins and other components have been identified using mass spectroscopy (Kumar et 
al., 2009; Utleg et al., 2003).  Some of the earliest identified compounds protect sperm 
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from the harsh environment encountered after transfer and provide nutrients to sperm.  
The highest concentration of a number of components derived from the prostate have 
been identified as citric acid, spermine, zinc, prostate specific antigen (PSA), and 
prostatic acid phosphatase (reviewed in Burden et al., 2006).  The precise roles of these 
factors in fertility are not known.  For instance, citric acid will bind metal ions, such as 
zinc, which inhibits several proteases in sperm (reviewed in Burden et al., 2006; Veveris-
Lowe et al., 2007).  However, the binding of metal ions by citric acid and subsequent 
inhibition of proteases havesot been shown to have functional relevance in altering a 
sperm cell’s fertilization ability or motility.  Furthermore, many components of 
mammalian seminal fluid may have roles in modulating female immunity.  For example, 
TGFβ and prostaglandins, known immunosuppressors, are present at a high concentration 
in seminal fluid.  The high level of these molecules may protect sperm from the female 
immune response (reviewed in Bronson, 2011), although a clear function has not been 
demonstrated. 
 A class of proteins that has been shown to have a function in mammalian seminal 
fluid regulating motility is the semenogelins.  Semenogelins are proteins that form 
seminal clots after mating and inhibit sperm motility.  These clots persist for several 
minutes before being degraded by proteases.  Once the clots have liquefied, sperm 
motility once again increases.  Temporary inhibition of motility is thought to increase 
fertility, since males with a high proportion of prematurely hyperactivated sperm have 
reduced fertility (reviewed in de Lamirande, 2007).  A direct connection between the 
reduced motility and fertility has not been shown.  Within seminal fluid, exosomes, small 
vesicles that are 50 to 500 nm in size, are present (Ronquist and Brody, 1985).  These 
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exosomes are released from epididymis and prostate and are called epididymosomes and 
prostasomes, respectively.  Prostasomes can fuse with sperm, allowing for modification 
of the sperm membrane and the proteins that it contains (Ronquist et al., 1990).  
Epididymosomes, small vesicles, are used to transfer proteins and lipids to the sperm 
membrane.  One such protein is a cholesterol transporter, HE1 (Thimon et al., 2008). 
 Perhaps the best characterized organism for seminal fluid compounds and their 
functions is D. melanogaster.  Components of seminal fluid have been determined using 
multiple methods, including detecting expressed sequence tags in tissues that express 
seminal fluid and using mass spectroscopy to identify proteins that have been transferred 
during mating (reviewed in Avila et al., 2011).  The functions of proteins present in 
seminal fluid are better understood in flies due to the genetic techniques available. 
 Seminal fluid proteins in the fly have been shown to have diverse functions.  
While some components have been identified as having roles in sperm storage, other 
factors affect female behavior or physiology.  One of the most well-characterized seminal 
fluid proteins is sex peptide (Acp70A), a 36 amino acid protein.  Functions for sex 
peptide include altering gene expression in the female, increasing female egg production, 
and reducing female receptivity to remating (Chen et al., 1988; Peng et al., 2005).  For 
long-term female responses to mating, sex peptide must associate with sperm, a process 
that is modulated by four other seminal fluid proteins: CG9997, CG1652, CG1656, and 
CG17575.  After sperm are stored in the female, sex peptide is necessary to release sperm 
from the sperm storage organs (Ram and Wolfner, 2007).  Another well-characterized 
seminal fluid protein is ovulin (Acp26Aa), which also stimulates egg production 
(Herndon and Wolfner, 1995).  For this stimulation to occur, ovulin must be cleaved by a 
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protease, CG11864 (Ravi Ram et al., 2006).  A third well-characterized protein is 
Acp36DE, which is necessary for the progression of changes in the female sperm storage 
organ.  These changes are thought to aid in sperm storage, such that fewer sperm from 
Acp36DE mutant males are stored in the female after mating (Avila and Wolfner, 2009).  
Despite the identified roles for these proteins, the mechanisms that affect the observed 
changes are unknown.  In addition, no protein has been shown to act directly on sperm to 
modulate sperm motility. 
 In the worm C. elegans, little is known about seminal fluid.  Prior to this 
dissertation, plg-1 was the only suspected seminal fluid component.  While plg-1 was 
shown to be expressed in the vas deferens of worms, it was not been shown directly to be 
transferred.  Instead, mating plugs were labeled using a lectin that labels a carbohydrate 
modification that is common to mucins (Palopoli et al., 2008). 
 Despite this lack of knowledge about specific components of seminal fluid, there 
is some evidence for a role of seminal fluid in worm fertility.  One potential role is 
regulation of sperm motility.  Sperm activation can be signaled in vitro using a variety of 
compounds.  These compounds include Pronase, a mixture of proteases; triethanolamine 
(TEA) a weak base; and monensin, an ionophore (Nelson and Ward, 1980; Shakes and 
Ward, 1989; Ward et al., 1983).  Combined with the observation that spermatids lack the 
machinery necessary to make proteins (Ward, 1986), activation of sperm by these 
components suggests that extracellular compounds in vivo signal sperm activation.  These 
signals could come from either the hermaphrodite or the male.  If the signals are male 
based, the signal would likely be in seminal fluid, which is released at mating.  However, 
evidence exists that seminal fluid might not be necessary for full male fertility.  If sperm 
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are removed from the seminal vesicle, washed, and injected into a hermaphrodite’s 
uterus, sperm activate and successfully fertilize the hermaphrodite’s oocytes (LaMunyon 
and Ward, 1995).  Due to the difficulty of introducing sperm into a hermaphrodite, it was 
not possible in these experiments to get an estimate of the percentage of sperm that 
fertilized an oocyte.  Thus, while seminal fluid is not strictly necessary for male fertility, 
seminal fluid might still improve male fertility. 
 
Seminal fluid proteases 
 Proteases have been shown to be common major components of seminal fluid in 
both flies and mammals.  However, protease involvement in fertility has been difficult to 
study in mammals due to redundancy.  For instance, there are at least 11 kallikrein 
proteases in human seminal fluid, ten of which are predicted to have trypsin-like activity.  
The exception is prostate-specific antigen (PSA), which has chymotrypsin-like activity 
and cleaves preferentially after tyrosine.  PSA has been implicated in several aspects of 
seminal fluid biology; most significantly in the cleavage of semenogelins, where PSA 
cleavage of semenogelins after mating degrades these proteins, so that sperm regain 
motility.  Furthermore, the products of semenogelin cleavage have been implicated in 
such processes as signaling an increase in sperm motility and increasing antibacterial 
activity (reviewed in Veveris-Lowe et al., 2007).  However, this process may also be 
dependent on other kallikreins, as they are also able to cleave semenogelins. 
 Fly seminal fluid has also been found to have multiple proteases.  Some of these 
proteases are major components of seminal fluid.  One protease, CG11864, has been 
identified as being necessary for the processing of ovulin and Acp36DE (Ravi Ram et al., 
2006).  However, CG11864 must be activated, which is accomplished by another 
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protease, seminase (CG10586).  Without CG11864 or seminase, an increase in egg laying 
is delayed.  Without seminase, sperm release, but not sperm storage, from the 
spermatheca is reduced (LaFlamme et al., 2012).  This is the first protease cascade 
identified in seminal fluid.  However, 15 proteases are in seminal fluid, suggesting that 
proteases may have more roles in modulating fertility (Findlay et al., 2008). 
 
Seminal fluid protease inhibitors 
 Where there are proteases, protease inhibitors are often present to regulate their 
activities.  Premature or inappropriate cleavage of proteins can produce negative effects.  
For instance, a protease inhibitor in mice, seminal vesicle protease inhibitor (SVI), 
associates with the acrosomal region of sperm (Irwin et al., 1983).  This association has 
suggested that protease inhibitors might block the acrosome reaction from occurring 
prematurely, since inhibition of SVI with an antibody results in the acrosome reaction 
(Aarons et al., 1991). 
 A seminal fluid protease inhibitor has also been found in flies, Acp62F.  While 
this inhibitor has not been shown to have a function in fertility, it has been found in the 
female’s hemolymph after mating (Lung and Wolfner, 1999).  Ectopic expression of this 
inhibitor shortens the fly’s life, and thus has been proposed to signal the shortened 
lifespan of females after mating (Lung et al., 2002).  Thirteen additional protease 
inhibitors are present in seminal fluid, which suggests that tight regulation of proteases 
occurs in seminal fluid (Findlay et al., 2008). 
 In C. elegans, a protease inhibitor that is likely to be associated with seminal fluid 
proteins has been characterized.  This protease inhibitor, SWM-1, encodes a protein with 
two trypsin inhibitor-like domains.  The pattern of expression for swm-1 has not been 
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determined; however, the SWM-1 protein does have a secretion signal and seems to be 
expressed in somatic tissue (Stanfield and Villeneuve, 2006).  swm-1 mutant sperm are 
activated, suggesting that SWM-1 protein inhibits a protease signal of sperm activation. 
 
Summary 
 Seminal fluid has been shown to have important roles in male fertility, but the 
roles of seminal fluid remain poorly understood.  Functional redundancy within 
mammalian seminal fluid has hindered understanding of its individual components of 
seminal fluid.  While some seminal fluid components, such as Hv1 and CatSper channels, 
are not conserved from humans to model organisms, model organism have allowed for 
understanding of how different proteins can function in seminal fluid.  The classes of 
proteins involved in sperm fertility are conserved; however, they frequently have 
different roles in ensuring fertility when compared between organisms.  Thus, study of 
model organism seminal fluid may provide an understanding of human fertility and how 
sperm motility can be regulated. 
 In this dissertation I describe a protease, TRY-5, that has roles in male sperm 
activation in C. elegans.  I have shown that this protein is necessary for the swm-1 
premature sperm activation phenotype.  The TRY-5 protein acts as a likely signal for the 
male sperm activation pathway, since TRY-5 is capable of bypassing the SPE-8 group 
activation pathway.  TRY-5 is a seminal fluid protein that is transferred during mating.  A 
transgenic copy of a TRY-5 and GFP fusion allows for observing the transfer of TRY-5.  
With this transgene, an additional tissue of seminal fluid origination has been found: 
TRY-5 is first secreted from the vas deferens and then the valve region, followed by 
sperm transfer.  These results suggest a model in which TRY-5 is a seminal fluid protease 
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and acts as a male sperm activator that is partially redundant with the unidentified 
hermaphrodite activator. 
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TRY-5 IS A SPERM-ACTIVATING PROTEASE IN 
 






 Seminal fluid proteins have been shown to play important roles in male 
reproductive success, but the mechanisms for this regulation remain largely unknown.  In 
Caenorhabditis elegans, sperm differentiate from immature spermatids into mature, 
motile spermatozoa during a process termed sperm activation.  For C. elegans males, 
sperm activation occurs during insemination of the hermaphrodite and is thought to be 
mediated by seminal fluid, but the molecular nature of this activity has not been 
previously identified.  Here we show that TRY-5 is a seminal fluid protease that is 
required in C. elegans for male-mediated sperm activation.  We observed that TRY-
5::GFP is expressed in the male somatic gonad and is transferred along with sperm to 
hermaphrodites during mating.  In the absence of TRY-5, male seminal fluid loses its 
potency to transactivate hermaphrodite sperm.  However, TRY-5 is not required for either 
hermaphrodite or male fertility, suggesting that hermaphrodite sperm are normally 
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activated by a distinct hermaphrodite-specific activator to which male sperm are also 
competent to respond.  Within males, TRY-5::GFP localization within the seminal 
vesicle is antagonized by the protease inhibitor SWM-1.  Together, these data suggest 
that TRY-5 functions as an extracellular activator of C. elegans sperm.  The presence of 
TRY-5 within the seminal fluid couples the timing of sperm activation to that of transfer 
of sperm into the hermaphrodite uterus, where motility must be rapidly acquired.  Our 
results provide insight into how C. elegans has adopted sex-specific regulation of sperm 
motility to accommodate its male-hermaphrodite mode of reproduction. 
 
Author summary 
 Sexual reproduction requires the generation of highly specialized gametes, eggs 
and sperm, that must encounter one another and fuse together to form a zygote.  Males 
provide not only sperm but also seminal fluid, which contains a variety of factors that 
promote male fertility through effects on sperm and on female physiology.  We have 
identified a C. elegans seminal fluid protease, TRY-5, which regulates sperm activation, 
the process by which immature spermatids complete their differentiation to a motile form 
capable of fertilizing an oocyte.  We observed release of TRY-5 that coincided with 
transfer of sperm, coupling the onset of sperm motility to transfer during mating.  
Although TRY-5 functions only in males, both male and hermaphrodite sperm are 
capable of responding to it.  TRY-5 is not required for fertility, and we propose that a 
hermaphrodite activator compensates in its absence.  Our results reveal how sperm 
development can be differentially modulated by males and hermaphrodites to promote 






A general feature of sexual reproduction is the generation of motile sperm that 
can navigate to an egg.  To assist this process, males transfer their sperm along with 
seminal fluid, which enhances their reproductive success in a variety of ways (reviewed 
in Pitnick et al. (2009) and Poiani (2006)).  Seminal fluid factors promote sperm survival, 
motility and fertilizing ability both by directly interacting with sperm and by interacting 
with tissues of the female to make her reproductive tract a more permissive environment.  
These factors include seminal fluid-specific proteins, a variety of hormones, and energy 
sources (Poiani, 2006).  In mammals, roles for seminal fluid factors include the regulation 
of sperm motility and capacitation and the modulation of immune function (Poiani, 2006; 
Yoshida et al., 2008).  Extensive analysis in Drosophila has identified many seminal fluid 
proteins and uncovered roles for several of these factors in sperm storage, sperm 
competition, female reproductive behavior and physiology, and other processes (Avila et 
al.).  Due to their potential for influencing reproductive success, components of seminal 
fluid represent a forum for both conflict and cooperation between the sexes (Pitnick et al., 
2009; Wolfner, 2009).   
The androdioecious nematode Caenorhabditis elegans provides an opportunity to 
analyze sperm development and function in a context where both sexes produce sperm 
and can differentially regulate gamete function to promote their fertility.  Hermaphrodites 
are self-fertilizing; during development, they produce a store of “self-” sperm, which can 
be used to fertilize their eggs.  Males mate with and transfer sperm to hermaphrodites.  




with extremely high efficiency; more than 99% of self-sperm are used.  However, if male 
sperm are present, then they preferentially fertilize eggs (Ward and Carrel, 1979).   
C. elegans sperm, like those of other nematodes, lack flagella; instead, they move 
by crawling using a pseudopod (Justine, 2002; Smith, 2006; Ward, 1977; Ward and 
Carrel, 1979).  Motility is acquired during sperm activation, a process analogous to 
spermiogenesis in flagellate sperm, in which haploid spermatids undergo a dramatic 
cellular rearrangement to become competent for both directional motility and fertilization 
of an oocyte (Ward and Carrel, 1979).  While most aspects of sperm development are 
similar in males and hermaphrodites, the timing and context of activation differ in the 
two sexes.  In hermaphrodites, spermatids activate when they move into the 
spermathecae, regions of the gonad where sperm are stored and fertilization occurs.  In 
males, sperm are stored in a nonactivated form and become activated after mating and 
transfer to a hermaphrodite ((Ward and Carrel, 1979) and unpublished observations).  
Sperm also can be activated in vitro in response to treatment with a variety of factors, 
including an ionophore (monensin), proteases (Pronase), a weak base (triethanolamine/ 
TEA), and an ion channel inhibitor (4,4’-diisothiocyano-2,2’-stilbenedisulfonic acid/ 
DIDS) (Machaca et al., 1996; Nelson and Ward, 1980; Shakes and Ward, 1989; Ward et 
al., 1983). This ability, together with the observation that sperm generally activate in vivo 
in response to a change in location, suggests that activation is controlled by extracellular 
signals.   
Genes that regulate sperm activation show distinct requirements in 
hermaphrodites and males.  The activity of a set of five genes termed the “spe-8 group” 




self-sperm; hermaphrodites mutant for any one of these genes are self-sterile, while 
mutant males are fertile (Geldziler et al., 2005; L'Hernault et al., 1988; Minniti et al., 
1996; Muhlrad and Ward, 2002; Nance et al., 2000; Nance et al., 1999; Shakes and Ward, 
1989).  Mating of spe-8 group mutant hermaphrodites with males results in self-sperm 
activation (“transactivation”) and can restore self-fertility, suggesting that males provide 
their own activator to which spe-8 group hermaphrodite sperm can respond (Shakes and 
Ward, 1989).  spe-8 group functions are dispensable for production of this activator, since 
both wild-type and spe-8 group males are competent for transactivating hermaphrodite 
sperm.  While these analyses indicate that there are differences in the intracellular 
pathways by which sperm are activated in the two sexes, the functions of individual 
activation genes are not strictly limited to a specific sex.  spe-8 group mutant male sperm 
show some defects, failing to activate in response to Pronase in vitro  (Geldziler et al., 
2005; Minniti et al., 1996; Nance et al., 2000; Shakes and Ward, 1989).  Furthermore, 
some spe-8 group activity is likely required for sperm to transactivate, since animals 
harboring spe-8 group null alleles appear to be insensitive to male activator (Geldziler et 
al., 2005; Nance et al., 2000).  While most analysis has focused on hermaphrodite sperm 
activation, a gene with a male-biased effect has been identified as well.  Activity of an 
extracellular trypsin inhibitor-like protein, SWM-1, is required in males to prevent 
premature activation from occurring prior to mating, and swm-1 mutant males are 
infertile due to failure to transfer activated sperm (Stanfield and Villeneuve, 2006).   
swm-1 activity is dispensable in hermaphrodites, though loss of swm-1 improves fertility 
in a sensitized spe-8 group mutant background (Stanfield and Villeneuve, 2006).  The 




of proteases to activate sperm in vitro, suggested that protease activity could signal 
activation in vivo.  However, the endogenous activator has not been identified as yet in 
either sex.   
Here, we report the identification of a trypsin-family serine protease, TRY-5, 
which has the properties expected of a male sperm activator.  Loss of try-5 suppresses 
mutations in swm-1.  Furthermore, during mating, TRY-5 is released from the somatic 
gonad and transferred along with sperm, thus coupling the onset of sperm motility to the 
time of their transfer to a hermaphrodite.  Within the male gonad, TRY-5 activity must be 
held in check to ensure male fertility.  Strikingly, TRY-5 is not required for male fertility, 
but strains lacking both try-5 and spe-8 group activation functions are totally sterile, 
confirming that while male and hermaphrodite sperm motility is induced by distinct 
signals, the two pathways are redundant.  In summary, TRY-5 is the first factor 
demonstrated to be a transferred component of seminal fluid in C. elegans, where it plays 




C. elegans male sperm activation is regulated by a protease 
 In wild-type males, sperm are stored in the inactive form within the seminal 
vesicle (Figure 2.1A) and become activated after transfer to a hermaphrodite ((Ward and 
Carrel, 1979) and unpublished data).  Mutations in the secreted protease inhibitor SWM-1 
result in premature sperm activation within males (Figure 2.1B, Figure 2.S1A, (Stanfield 
and Villeneuve, 2006)).  We predicted that loss of activation-promoting factors should 
suppress this phenotype.  To identify such factors, we performed genetic screens for 




swm-1(me86) or swm-1(me66) (G.M.S., unpublished; (Stanfield and Villeneuve, 2006)).  
Among the swm-1 suppressor mutants, we identified three alleles of the serine protease 
gene try-5 (Figure 2.1E and 2.1F).  We subsequently obtained tm3813, a deletion 
affecting the 5’ end of the try-5 coding region (gift of S. Mitani, National Bioresource 
Project, Japan), and showed that it also suppressed swm-1(me86) (Figure 2.1F).  
Suppression of the premature activation phenotype in swm-1 try-5 double mutants was 
rescued by a genomic fragment containing the full-length try-5 gene (Figure 2.1G, Tables 
2.S1, 2.S2, 2.S3 and data not shown), confirming that try-5 was responsible for this 
effect. 
In parallel to our forward genetic screen, we also tested individual serine proteases for 
a role in sperm activation.  We used RNA interference to reduce the function of 
individual protease genes in a swm-1 mutant background and screened for effects on 
premature activation in males.  Among the tested proteases, only reduction of try-5 
resulted in strong suppression (Materials and Methods and data not shown), consistent 
with our finding that try-5 is a regulator of sperm activation. 
Based on conservation of its sequence and domain structure (Marchler-Bauer et al., 
2009) with those of the trypsin-like superfamily, try-5 is predicted to encode a trypsin-
class serine protease.  This family of proteases contains numerous members in eukaryotes 
and regulates many processes, including blood coagulation, developmental signaling and 
fertilization (Di Cera, 2009).  Specific residues that form the protease active site are 
conserved in TRY-5, and the presence of a signal sequence on the N terminus of the 
protein suggests that it is secreted (Figure 2.S2).  While TRY-5 has clear orthologs in 




related species (data not shown). In addition, its substrate-binding region is divergent 
from those of trypsin family members with characterized substrate specificities (Perona 
and Craik, 1995).   
 We initially identified try-5 using partial loss-of-function alleles of swm-1.  To 
determine whether mutations in try-5 are capable of suppressing a swm-1 null, we 
examined animals harboring both the null allele swm-1(me87) and an allele of try-5.  We 
found that whereas swm-1(me87) mutant males contain activated sperm (Stanfield and 
Villeneuve, 2006), swm-1(me87) try-5(jn2) and swm-1(me87) try-5(tm3813) males 
contained nonactivated sperm like those found in the wild type or in a try-5 mutant 
((Stanfield and Villeneuve, 2006), Figure 2.1A-2.1D and 2.1F, Figure 2.S1).   In 
summary, these results indicate that the protease TRY-5 is responsible for the premature 
sperm activation and associated loss of fertility that occur in swm-1 mutant males and 
suggest that the function of SWM-1 is to inhibit TRY-5 activity within the male.   
 
Male sperm can activate in the absence of try-5 
To see if try-5 is required for male sperm to activate, we assessed the ability of 
try-5 mutant sperm to respond to treatments that bypass normal activation signals.  Wild-
type sperm can be activated in vitro by treatment with any of a variety of compounds 
(Machaca et al., 1996; Nelson and Ward, 1980; Shakes and Ward, 1989; Ward et al., 
1983).  Since TRY-5 is predicted to be a protease, we first assayed the ability of try-5 
mutant spermatids to activate in response to Pronase treatment.  In the absence of 
Pronase, both wild-type and try-5 mutant sperm remained nonactivated (Figure 2.2A and 
2.2B).  Within 5 to 10 min after addition of Pronase, the majority of sperm cells 




PronaseAct).  These cells were capable of motility, as they were observed crawling 
across the microscope slide (note altered positions of some cells in Figure 2.2B vs. Figure 
2.2C).  There was no significant difference in either the level of activation (Figure 2.2A; 
P=0.89, Student’s t test) or the rate of activation (data not shown) of try-5 mutant sperm 
as compared to the wild type.  We then tested the ability of try-5(tm3813) spermatids to 
activate in response to treatment with a second known activator, the weak base TEA.  
When treated with TEA, try-5 mutant spermatids activated at levels similar to wild-type 
sperm (data not shown).  Thus, try-5 is not required for sperm activation initiated in vitro 
either by exogenous proteases or TEA.  This result distinguishes try-5 mutants from the 
previously-characterized spe-8 group mutants, for which sperm activate normally when 
treated with TEA, but arrest at a partially-activated, “spiky” stage in response to Pronase 
(Geldziler et al., 2005; Minniti et al., 1996; Nance et al., 2000; Shakes and Ward, 1989).     
We next determined if try-5 is required for activation induced by loss of the 
intracellular activation inhibitor spe-6.  SPE-6 is a sperm casein kinase 1-like protein that 
functions at two points during spermatogenesis: during spermatogenic cell divisions 
(Varkey et al., 1993) and later during sperm activation (Muhlrad and Ward, 2002).  
Specific mutations in spe-6 allow spermatogenesis to occur but lead to premature sperm 
activation in males, a phenotype that is thought to be independent of extracellular 
signaling (Muhlrad and Ward, 2002).  To determine whether try-5 function is required for 
the premature sperm activation phenotype of spe-6, we assayed sperm activation in spe-
6(hc163); try-5(tm3813) and spe-6(hc163); try-5(jn2) mutant males.  We found that, like 
spe-6(hc163) mutant males, spe-6(hc163); try-5 males contained activated sperm (Table 




shown).   Thus, TRY-5 activity does not function downstream of the sperm protein SPE-
6.  Together, the ability of try-5 sperm to activate in response to either in vitro activators 
or loss of an intracellular inhibitor indicates that TRY-5 is not required for the subcellular 
rearrangements of sperm activation. Rather, these data suggest a regulatory role for this 
protease in signaling sperm to initiate the activation process. 
 
try-5 is not required for fertility 
Since activation is necessary to generate mature, motile spermatozoa that are 
competent for fertilization, failure to activate results in infertility.  If try-5 is required for 
sperm activation, then loss of try-5 should result in decreased fertility.  To test this idea, 
we assayed fertility in try-5 and swm-1(me87) try-5 hermaphrodites and males, using the 
try-5 alleles jn2 and tm3813.  In self-fertilizing hermaphrodites, sperm is the limiting 
gamete for offspring production; nearly every self-sperm in a hermaphrodite will fertilize 
an oocyte (Ward and Carrel, 1979), so the total self-brood size is a sensitive measure of 
the number of functional, activated sperm produced.  We found no significant difference 
between the number of progeny produced by try-5 or swm-1 try-5 mutant hermaphrodites 
as compared to wild-type and swm-1 controls (Figure 2.3A, Figure 2.S3A).  Thus, try-5 is 
not required for hermaphrodite sperm activation or fertility.   
We next measured male fertility in crosses of individual males to spe-8(hc40); 
dpy-4 recipient hermaphrodites.  While there was a great deal of variation in the number 
of cross progeny produced even by wild-type males, as observed previously (Ward and 
Miwa, 1978), try-5 mutant males showed a high level of fertility and no significant 
difference with the wild type was observed (Figure 2.3B).  In addition, swm-1 try-5 males 




2.S3B), along with suppression of the swm-1 transfer defect (data not shown).  While our 
assays detected no obvious fertility defects in try-5 animals, it is possible that they might 
exhibit reduced fertility in other situations, e.g., outside the laboratory or under 
conditions of sperm competition.  However, these results suggest that try-5 is not 
required for sperm activation or other aspects of fertility in either sex.   
 
try-5 and the spe-8 group define two pathways 
for sperm activation 
Although try-5 is not required for either male or hermaphrodite fertility, there is 
previous evidence for distinct pathways of sperm activation in males vs. hermaphrodites 
(L'Hernault et al., 1988; Shakes and Ward, 1989), raising the possibility that the effect of 
try-5 loss is masked by functional redundancy.  Therefore, we tested genes in the 
hermaphrodite pathway for redundancy with try-5.  The activities of a set of five genes 
termed the “spe-8 group” (spe-8, -12, -19, -27, and -29) are required for self-sperm 
activation in the hermaphrodite but not for activation of male sperm (reviewed in 
(L'Hernault, 2006)).  To test whether try-5 and the spe-8 group function in independent, 
redundant activation pathways, we assayed sperm activation and male fertility in worms 
lacking both try-5 and spe-8 group activity, using the spe-8 group mutations spe-
27(it110) and spe-29(it127).  While spe-27 mutant males are fertile and capable of 
generating cross progeny, we found that spe-27; try-5 mutant males were completely 
infertile (Figure 2.3C).  Similarly, while spe-29 mutant males are fertile, spe-29; try-5 
fertility was greatly reduced as compared to the wild type (Figure 2.3C).   
To investigate the cause of this infertility, we labeled males with MitoTracker 




sperm transfer and migration (Stanfield and Villeneuve, 2006).  We found that spe-27; 
try-5 males were able to transfer sperm to hermaphrodites, but the transferred sperm did 
not migrate. Similarly, for spe-29; try-5 males, we observed only rare instances of 
successful migration (Table 2.S4 and data not shown).  To determine if the migration 
defect was due to improper activation or a defect in migration after sperm activation, we 
dissected hermaphrodites immediately after their mating to spe-27; try-5 males and 
examined transferred, MitoTracker-labeled sperm.  We found that whereas spe-27 sperm 
activate within 15 minutes after transfer to a hermaphrodite, spe-27; try-5 sperm fail to 
activate (data not shown).  Thus, spe-27; try-5 males are infertile due to failure to activate 
sperm upon transfer to hermaphrodites.  Our findings of residual fertility and sperm 
migration in spe-29; try-5 males are consistent with previous observations (Nance et al., 
2000) that the single known mutation in spe-29 leads to a weaker phenotype as compared 
to known null mutations in other spe-8 group genes.  These results suggest that try-5 
activity is the source of fertility in spe-8 group mutant males; i.e., the spe-8 group and 
try-5 function in two separate pathways for sperm activation, and either pathway is 
normally sufficient for full male fertility.   
 
try-5 mutant males do not transfer activator to hermaphrodites 
To determine whether try-5 indeed functions in the male-derived activation 
pathway, we used a specific assay to measure transfer of functional male activator. Wild-
type male seminal fluid is capable of activating spe-8-group mutant hermaphrodite sperm 
during mating; this process is termed “transactivation” and is generally assayed using fer-
1 mutant males, which are defective for producing functional sperm, to prevent cross-




1978) or fer-1; try-5 males to spe-8(hc53); dpy-4 hermaphrodites and counted the number 
of self-progeny generated.  Crosses with fer-1 control males resulted in transactivation 
approximately 58% of the time.  However, fer-1; try-5 males were rarely if ever capable 
of transactivating hermaphrodite sperm (Figure 2.4).  To exclude the possibility that fer-
1; try-5 males simply might harbor a behavioral defect that reduced their mating 
frequency, we used MitoTracker to label males and assessed their ability to transfer 
sperm.  We observed similar frequencies of hermaphrodites containing labeled sperm 
after incubation with fer-1 males, fer-1; try-5(jn2) males, or fer-1; try-5(tm3813) males 
(43%, 57%, or 63%, respectively).  These data indicate that fer-1; try-5 mutants mate and 
transfer sperm with similar success rates as compared to the control.  Thus, try-5 mutant 
males are defective in transfer of the male activator responsible for transactivation of spe-
8 group hermaphrodite sperm. 
 
TRY-5 is expressed in and secreted 
from the male somatic gonad 
To determine how TRY-5 functions in male sperm activation, we sought to 
determine where it is expressed and localized.  Since we predicted that TRY-5 protein is 
secreted, we generated both a Ptry-5::GFP::H2B transcriptional reporter, a histone-H2B 
fusion that localizes to cell nuclei and facilitates identification of cells, and a Ptry-
5::TRY-5::GFP translational reporter for assessing TRY-5 protein localization and 
function.  We created stable transgenic worm strains using MosSCI (Mos1-mediated 
Single Copy gene Insertion (Frokjaer-Jensen et al., 2008), Tables 2.S1 and 2.S2) and 
confirmed that the Ptry-5::TRY-5::GFP transgene restored a premature sperm activation 




Using the Ptry-5::GFP::H2B reporter, we found that the primary site of try-5 
expression was in the male somatic gonad, in particular within tissues involved in storing 
sperm and tissues through which sperm pass during transfer to a hermaphrodite.  The C. 
elegans male gonad is essentially a long tube. At the distal end of this tube, germline 
stem cells reside and proliferate, and as they move proximally, they undergo meiosis and 
differentiate into spermatids.  A subset of somatic gonadal cells surround spermatids to 
form a storage organ, the seminal vesicle; a more proximal set forms a channel, the vas 
deferens, through which sperm move during transfer.  A valve structure regulates 
movement of sperm between the seminal vesicle and vas deferens.  The vas deferens 
contains at least two distinct cell types, based on shape: cuboidal and elongated cells 
(Lints and Hall, 2009).  Beyond an obvious structural role, other functions of these 
different cell types are not known, although some of them appear to be involved in 
secretion (Lints and Hall, 2009).  Starting at the L4 larval stage, when sperm production 
initiates, we observed Ptry-5::GFP::H2B expression in several regions of the male gonad 
(Figure 2.5A): the seminal vesicle (up to 7 of the 23e total cells in this tissue (Kimble and 
Hirsh, 1979)), the valve region (four cells), and the 12 cuboidal cells of the vas deferens 
(Lints and Hall, 2009).  This overall pattern persisted into adulthood until at least 72 hr 
post-L4; highest expression levels were present consistently in the valve region.  We 
observed no expression in the hermaphrodite gonad, so gonadal expression of try-5 is 
sexually dimorphic.  However, we also observed low levels of expression in a few cells 
within the head and tail of both males and hermaphrodites (data not shown).  
In worms carrying the Ptry-5::TRY-5::GFP reporter, the TRY-5::GFP fusion 




Within the valve and cuboidal cells, TRY-5::GFP was localized to globular foci.  In L4 
larvae, most globules aligned with the apical domain that lines the developing sperm 
channel (Figure 2.5B).  In mature adults, very large globules were present that tended to 
cluster apically, and additional small globules were present throughout the cytoplasm 
(Figure 2.5C and 2.5D).  Such large globular structures are generally visible in adult 
males by DIC microscopy and diagnostic of vas deferens tissue, including within wild-
type animals lacking a transgene.  Based on their size and location, these large globules 
are likely to represent the “secretory globules” observed by electron microscopy (Lints 
and Hall, 2009).   
We sometimes observed TRY-5::GFP within the lumen of the seminal vesicle, 
likely as a result of release from the adjacent, highly-expressing valve cells (Figure 2.5D 
and 2.5E, Table 2.S5).  The timing and extent of TRY-5::GFP expansion into the seminal 
vesicle was dependent on activity of the protease inhibitor SWM-1, the level of 
expression, and male age.  In animals wild-type for swm-1, TRY-5::GFP was usually 
restricted to the valve cells or regions close by; when present near sperm cells, TRY-
5::GFP was usually localized to a few discrete foci (data not shown).  However, in 
animals lacking swm-1 activity, we often observed large zones of TRY-5::GFP extending 
from the valve and surrounding sperm in the seminal vesicle (compare Figure 2.5C and 
2.5D; see Table 2.S5).  Even in swm-1(+) animals, when high levels of TRY-5::GFP 
were present in the seminal vesicle, we almost always observed that sperm were activated 
(Figure 2.5E, Tables 2.S3 and 2.S5).  Together, these data suggest that TRY-5 is 
produced by cells of the male somatic gonad and can induce sperm activation within 




wild-type males sometimes contain activated sperm (Stanfield and Villeneuve, 2006), and 
the finding that TRY-5::GFP is released into the seminal vesicle in older males provides a 
basis for this phenotype. Thus, these results support a model in which TRY-5 acts locally 
on sperm, either to signal their activation or to generate such a signal, and SWM-1 acts to 
inhibit the accumulation and/or activity of TRY-5 in the seminal vesicle. 
 
TRY-5 is transferred to hermaphrodites during mating 
Since TRY-5 localization is consistent with secretion from the male gonad, we 
sought to determine whether TRY-5 is transferred during mating.  We placed individual 
MitoTracker-labeled Ptry-5::TRY-5::GFP; try-5(tm3813) males with unc-52 
hermaphrodites, monitored the males for mating behavior (Barr and Garcia, 2006), and 
acquired fluorescence images starting at or just before spicule insertion.  We observed 
that TRY-5::GFP was transferred to hermaphrodites during mating (Figure 2.6 and Video 
TRY5transfer).  Shortly after spicule insertion, TRY-5::GFP was released from the vas 
deferens and transferred to the hermaphrodite (Figure 2.6A and 2.6B).  A brief pause 
without obvious transfer then occurred (Figure 2.6C).  Next, TRY-5::GFP was released 
from the valve cells and travelled rapidly through the vas deferens into the hermaphrodite 
(Figure 2.6D and 2.6E).  Movement of this valve pool was immediately followed by 
transfer of sperm (data not shown).  After transfer, the TRY-5::GFP signal dispersed 
throughout the uterus (Figure 2.6F) and remained visible near the vulva for several 
minutes, if eggs were not laid immediately.  This stereotypical series of events occurred 
for all cases (n=5) in which the entire process was observed from spicule insertion to 
sperm transfer.  We also observed a partial time course of five other matings, all of which 




To confirm that this behavioral sequence is not unique to this specific 
hermaphrodite genotype, we mated Ptry-5::TRY-5::GFP; try-5(tm3813) males to either 
unc-31 (n=4) or him-5 unc-76 (n=3) hermaphrodites.  We were unable to observe vas 
deferens TRY-5::GFP transfer in these cases due to excess hermaphrodite movement.  
However, we did observe that valve TRY-5::GFP transfer initiated approximately 15-55 
sec after spicule insertion, which is similar to the time observed for mating with unc-52 
hermaphrodites (Figure 2.6, Video TRY5transfer and data not shown) and consistent with 
the reported timing for sperm transfer from 14.4 to 90.2 sec after spicule insertion as 
determined by Schindelman (2006).  In summary, our data suggest that TRY-5 is a 
seminal fluid protein that is transferred to the hermaphrodite during copulation. 
Furthermore, our observations indicate that seminal fluid is released in discrete pools 
from specific tissues of the male gonad and that these events occur largely prior to and 




Activation of C. elegans sperm motility by a protease signal 
We have identified a serine protease, TRY-5, which functions in C. elegans male 
sperm activation, the process by which amoeboid sperm cells become motile and 
competent to fertilize an egg.  Based on our analysis of the defects of try-5 mutants and 
the dynamic localization of a TRY-5 reporter, we propose that TRY-5 is a sperm 
activating signal (Figure 2.7A and 2.7C).  TRY-5 function is required for premature 
activation of stored sperm in males lacking the protease inhibitor SWM-1.  TRY-5::GFP 
is expressed by the male somatic gonad within secretory cells.  When observed outside 




of activated sperm.  We have directly observed the transfer of TRY-5::GFP to 
hermaphrodites during copulation, and try-5 mutant males are incapable of transferring 
sperm activator to hermaphrodites.  Together, these data strongly support a model in 
which TRY-5 is a component of seminal fluid that is transferred during copulation to 
signal sperm activation.  Coupling the exposure of sperm to TRY-5 to the timing of 
transfer serves to ensure that sperm motility is rapidly induced at the time of - but not 
before - entry into a hermaphrodite’s reproductive tract, thereby promoting male fertility.   
Our discovery of a seminal fluid serine protease provides a mechanistic explanation 
for previous results linking extracellular protease activity with sperm activation in C. 
elegans and in other nematodes.  C. elegans sperm can be activated in vitro by incubation 
with Pronase, a protease preparation that primarily contains trypsin-like activity at the pH 
used for these assays (Ward et al., 1983).  In C. elegans males, loss of the SWM-1 
protease inhibitor, which should result in increased protease activity, results in increased 
activation (Stanfield and Villeneuve, 2006).  Recent studies of sex determination in C. 
remanei, a male-female species, showed that females could be transformed into sperm-
producing “pseudohermaphrodites,” but their sperm were not motile; production of 
functional, activated sperm could be achieved through additional inhibition of the C. 
remanei orthologue of swm-1 (Baldi et al., 2009).  Finally, the somatic gonad of males 
from the related nematode Ascaris suum contains a protease activity, which can activate 
sperm (Burghardt and Foor, 1978; Foor and McMahon, 1973).  Thus, a role for protease 
activity in promoting sperm motility appears to be conserved among nematodes.   
Here we describe a novel role for a protease as a signaling molecule for 




The onset of motility in C. elegans sperm, as in flagellate sperm, occurs at a stage 
subsequent to meiotic cell division and the compaction of the haploid genome.  At this 
stage, C. elegans sperm cells no longer express new protein products (L'Hernault, 2006).  
Therefore, to alter their behavior they must either reorganize their cellular contents in 
response to their environment or take in external factors.  In addition, the timing of 
activation must be tightly controlled: C. elegans sperm must become motile rapidly upon 
entry into the hermaphrodite to avoid being lost due to the continuous outward passage of 
eggs (Ward and Carrel, 1979), but early activation of motility precludes transfer of sperm 
from the male (Stanfield and Villeneuve, 2006).  A protease activator provides a 
mechanism to trigger irreversible changes in the sperm cell surface that is readily coupled 
to mixing of sperm with seminal fluid. This type of activator also provides a simple 
mechanism to hold activation in check: the use of specific protease inhibitors such as 
SWM-1. We propose that the balance of TRY-5 and SWM-1 activities controls the 
likelihood of activation in specific locations and times within the male and hermaphrodite 
(Figure 2.7).  For example, within the male gonad, SWM-1 may directly inhibit TRY-5 
activity to prevent activation, allowing for sperm transfer and maintaining male fertility 
(Figure 2.7A).  It is likely that additional proteases and/or inhibitors also function in this 
process.  try-5 mutant hermaphrodites are fertile, suggesting that hermaphrodites have an 
activator that is independent of TRY-5 (Figure 2.7B).  This activator could be a protease, 
though its identity is not known.  Male sperm sometimes activate prematurely in try-5 
mutants, suggesting that males could contain a second activator.  However, if it exists, 
such a secondary male activator must not be competent to activate male or hermaphrodite 




Genetic analysis of swm-1 had suggested that it functions to inhibit two distinct 
protease activities that act in parallel to promote sperm activation within males (Stanfield 
and Villeneuve, 2006).  This model was based on the result that partial loss-of-function 
mutations affecting each of the two TIL domains of SWM-1 partially complement one 
another.  By this model, loss of a single protease would not be expected to block sperm 
activation.  However, we find that all SWM-1 activity works through TRY-5 in males, 
suggesting that both domains of SWM-1 inhibit TRY-5.  The apparently separable 
activities of the SWM-1 TIL domains could arise from interactions with factors other 
than proteases.  Alternatively, these results can be reconciled by a regulatory model in 
which SWM-1 inhibits two distinct proteases, both of which act upstream of TRY-5.  It is 
also possible that SWM-1 might inhibit both TRY-5 and a second, TRY-5-activating 
protease.  Consistent with these ideas, many well-known protease pathways consist of 
sequential cascades of activator and effector functions (e.g., (Ovaere et al., 2009; 
Pampalakis and Sotiropoulou, 2007)).   
As an extracellular protease, TRY-5 likely signals activation by cleaving sperm cell 
surface proteins and altering their activity.  Some of the targets of TRY-5 may be SPE-8 
group proteins, based on the fact that TRY-5 is required for transactivation, a process 
dependent on having some spe-8 group activity (sperm from hermaphrodites harboring 
null alleles of these genes are essentially incapable of being transactivated (Geldziler et 
al., 2005; Nance et al., 1999)).  However, spe-8 group mutant males are fertile, 
suggesting that SPE-8 group proteins are not essential for activation in all contexts.  
Thus, other targets may not be members of the SPE-8 group.  The existence of such 




try-5) that show full fertility in hermaphrodites and so do not fall into the spe-8 
phenotypic class (G.M.S., unpublished data). 
Could TRY-5 be functioning in some role other than as a direct activator?  Sperm 
from try-5 mutant males can be activated within hermaphrodites after mating, in spe-6 
mutants, or by exogenous activators in vitro.  Thus, other activators can bypass TRY-5, 
and try-5 is not required for the cellular rearrangements that occur after activation is 
triggered.  These data support the idea that TRY-5 functions in a regulatory step of the 
activation process.  It is clear that TRY-5 is essential for transfer of sperm activator by C. 
elegans males and its localization correlates strongly with that of activated sperm. These 
data strongly suggest that if TRY-5 is not the signaling molecule per se, its activity is 
intimately associated with generation of the sperm activation signal.   
 
TRY-5 as a component of seminal fluid 
Production and transfer of seminal fluid is an important aspect of male reproduction 
(Gillott, 2003; Poiani, 2006; Wolfner, 2007).  TRY-5 is one of the first seminal fluid 
proteins identified in C. elegans.  Indeed, it is the first directly demonstrated to be 
transferred at mating, and the first with a specific role in promoting gamete function.  
Previously, plg-1 was identified as a seminal fluid factor required for production of a 
copulatory plug (Hodgkin and Doniach, 1997) and shown to encode a mucin-like protein 
with a function in male mate guarding (Palopoli et al., 2008).  plg-1 is expressed within 
the male somatic gonad in a subset of cells that express try-5; interestingly, plg-1 is not 
expressed within the valve region (Palopoli et al., 2008), from which most TRY-5 
appears to be released during mating (Video TRY5transfer).  Thus, as in other animals 




male gonad appear to be specialized to produce specific components of seminal fluid.  
Furthermore, our data reveal considerable complexity in the timing of release of seminal 
fluid from specific tissues during the mating behavioral program. 
 
Regulatory logic of sperm activation 
in a male-hermaphrodite species 
We have found that try-5 is functionally redundant for fertility in C. elegans.  
Although try-5 mutant males fail to transfer activator, they are fertile; however, loss of 
both try-5 and spe-8-group function leads to complete infertility for both hermaphrodites 
and males (tested here with mutations in two of the spe-8-group genes, spe-27 and spe-
29).  These data can be explained by the following model: spe-27; try-5 and spe-29; try-5 
animals (1) make sperm that do not respond to hermaphrodite activator (due to loss of 
spe-8-group function) and (2) do not produce male activator (due to loss of try-5).  In 
other words, try-5 males may be fertile due not to the presence of additional activators 
provided by the male, but rather due to rescue of male sperm activation by a signal within 
the hermaphrodite (Figure 2.7C).   
These findings of redundancy raise the question: why does C. elegans have try-5?  At 
least part of the answer might lie in the evolutionary history of this species, which 
evolved from a gonochoristic (male-female) ancestor (Cho et al., 2004; Kiontke et al., 
2004).  As the male activator, try-5 may represent the ancestral mode of activating sperm.  
Baldi et al. (2009) have shown that the transition from gonochorism to androdioecy in the 
related species C. remanei requires only two steps: making sperm and activating it.  
Acquisition of the ability to make sperm could be advantageous, even in the initial 




fertility.  Chance encounters with a male would potentially activate hermaphrodite self-
sperm, as long as hermaphrodite sperm remained capable of responding to male activator.  
In turn, the male may have developed mechanisms to ensure his sperm were used 
preferentially; indeed, C. elegans male sperm show strong precedence over those of the 
hermaphrodite (LaMunyon and Ward, 1995; Ward and Carrel, 1979).  Eventually, the 
hermaphrodite might evolve her own mechanism for activating sperm.  The self-sperm 
activator in C. elegans is not known, but it may be a serine protease.  Indirect evidence 
for this idea is provided by data indicating that the inhibitor SWM-1 functions in 
hermaphrodites: while animals mutant for the spe-8 class gene spe-29 have very low 
levels of self-sperm activation and fertility, this phenotype is partially suppressed by 
mutations in swm-1 (Stanfield and Villeneuve, 2006).  However, this protease is likely 
distinct from TRY-5, since we have found that try-5 is not required for either normal 
hermaphrodite fertility or increased activation in spe-29; swm-1 hermaphrodites (Figure 
2.3A, Figure 2.S4). 
Alternatively, production of TRY-5 would be advantageous for males if it is a more 
efficient activator than that of hermaphrodites.  While our fertility assays revealed no 
difference between fertility of wild-type and try-5 males, those assays were performed 
under highly permissive conditions: young adult animals were provided with many 
opportunities for mating to occur under conditions of unlimited food resources.  TRY-5 
might be important to increase reproductive fitness in less-than-ideal conditions.  For 
example, activation by TRY-5 might occur more rapidly than that mediated by the 
hermaphrodite activator.  If so, its transfer would decrease the chance that transferred 




In summary, our work has identified a serine protease in C. elegans male seminal 
fluid that regulates the timing of sperm activation to promote male fertility.  TRY-5 is 
transferred along with sperm during mating to couple sperm motility to entry into the 
hermaphrodite reproductive tract.  While TRY-5 appears to be necessary for males to 
signal activation, hermaphrodites contain their own activator.  Interestingly, these 
redundant pathways are competent to activate sperm from either sex, providing insight 
into the strategies used by C. elegans to adopt a male-hermaphrodite mode of 
reproduction.  Further dissection of these signaling pathways will require identifying 
targets of TRY-5 and determining the nature of the hermaphrodite activator. 
 
Materials and methods 
 
C. elegans genetics 
C. elegans strains were grown as described by Brenner (1974) at 20°C, except 
where otherwise noted.  All strains were derived from the wild-type isolate Bristol N2.  
To ensure a ready supply of males, a strain harboring the mutation him-5(e1490) 
(Hodgkin et al., 1979) was used as the wild type and him-5(e1490) was present in all 
other strains unless explicitly noted.  The try-5 alleles jn2 and jn13 were isolated as 
suppressors of swm-1(me86) and jn21 was isolated as a suppressor of swm-1(me66) 
(G.M.S., unpublished results).  Ethyl methanesulfonate (EMS) mutagenesis was 
performed as in (Wood, 1988).  try-5(tm3813) was a gift of S. Mitani (National 
Bioresource Project, Japan).  Other alleles (described in Wood (1988) unless otherwise 
noted) were: spe-8(hc40, hc53) I, fer-1(hc1ts) I, ttTi5605 II (Frokjaer-Jensen et al., 2008), 
unc-52(e444) II, dpy-18(e364) III, spe-6(hc163) III (Muhlrad and Ward, 2002), unc-




spe-29(it127) IV (Nance et al., 2000), dpy-20(e1282) IV, mIs11[myo-2::GFP, pes-
10::GFP, gut::GFP] IV, dpy-4(e1166) IV, unc-31(e169) IV, swm-1(me66, me86, me87) V 
(Stanfield and Villeneuve, 2006), unc-76(e911) V and nT1[unc-?(n754) let-? qIs50 ](IV, 
V).   
Strains containing mutations in both a spe-8 group gene and try-5 were 
maintained as heterozygotes using the balancer nT1. Homozygous spe-8 group; try-5 
males were generated by transactivation crosses of homozygous self-sterile 
hermaphrodites to swm-1 mutant males, which are competent for transferring seminal 
fluid but rarely transfer sperm (Stanfield and Villeneuve, 2006).  For example, for the 
spe-27 dpy-20/nT1; try-5 him-5/nT1 strain, homozygous spe-27 dpy-20; try-5 him-5 
hermaphrodites were selected and crossed to either swm-1(me87) him-5 or mIs11; swm-
1(me87) him-5 males to induce production of self-progeny, which can be recognized as 
being phenotypically Dumpy. 
To screen C. elegans proteases for a function in sperm activation, RNAi against 
individual protease genes was performed on swm-1 him-5 worm strains by feeding on 
agar plates essentially as described by (Ahringer, 2006).  Bacteria containing inducible 
RNAi clones (described in (Fraser et al., 2000; Kamath et al., 2003)) were obtained from 
Source BioScience.  Genes tested by RNAi were try-1, try-2, try-3, try-5, try-6, try-7, try-
8, F25E5.3, F25E5.4, F25E5.7, and F48E3.4.  For each gene, swm-1(me66) him-5 and 
swm-1(me86) him-5 eggs were collected on RNAi plates and allowed to grow to the L4 
stage; L4 males were then transferred to a fresh RNAi plate and scored either 24 hr or 48 







Sperm activation was assayed in virgin males collected as L4 larvae and 
incubated at 20°C for 48 hr, unless otherwise indicated.  To examine individual sperm 
cells, males were dissected in sperm medium (SM) (5mM HEPES sodium salt pH 7.4, 50 
mM NaCl, 25 mM KCl, 5 mM CaCl2, 1 mM MgSO4) supplemented with 10 mM 
dextrose (Nelson and Ward, 1980).  Samples were observed using differential 
interference contrast (DIC) microscopy and sperm were scored based on cell shape as 
either nonactivated, if spherical, or activated, based on the presence of a pseudopod.  
Samples were observed using an AxioImager M1 equipped with an AxioCam MRm 
(Zeiss). Confocal imaging was performed using a TCS SP2 (Leica).  Images were 
processed using ImageJ (Rasband, 1997-2009) and Photoshop (Adobe Systems). 
 
Fertility assays 
Hermaphrodite self-fertility was measured by picking individual hermaphrodites, 
transferring them to fresh plates every 1-2 days until no more eggs were laid, and 
counting the total progeny after worms reached the L4 stage.  Cases in which 
hermaphrodites failed to lay oocytes or died less than 4 days after adulthood were 
excluded from analysis. 
Male fertility was measured in 1:1 crosses to spe-8(hc40); dpy-4 hermaphrodites.  
L4 stage animals were placed together for 48 hr; hermaphrodites were then transferred to 
fresh plates without males and transferred again every 1-2 days until no more eggs were 
laid.  All cross progeny, identifiable by their nonDumpy phenotype, were counted after 
worms reached the L4 stage. Use of the spe-8 mutation in recipient hermaphrodites 




since transfer of seminal fluid leads to production of self-progeny (L'Hernault et al., 
1988; Stanfield and Villeneuve, 2006).  Cases in which mating was not confirmed or the 
hermaphrodite died less than 3 days after adulthood were excluded from analysis.  
For all fertility assays, wild-type broods were measured in parallel to those of the 
strain being assayed to control for variations in temperature, media quality and other 
factors that can affect progeny production or mating efficiency. 
 
Sperm and seminal fluid transfer assays 
To assay sperm transfer and migration, males were labeled with 1 µg/mL 
MitoTracker CMXRos (Invitrogen) as described by Chen et al. (2000) and observed as 
described previously (Stanfield and Villeneuve, 2006).   
Seminal fluid transfer (transactivation, (Shakes and Ward, 1989)) was assayed 
using males harboring the fer-1(hc1ts) mutation, which results in nonfunctional sperm at 
the restrictive temperature of 25°C (Ward and Miwa, 1978).  L4 males were crossed in a 
4:1 ratio to L4 spe-8(hc53); dpy-4 hermaphrodites for 48 hr at 25°C.  The number of self-
progeny (Dumpy offspring) produced during the mating period was determined after 3 
additional days. Any crosses resulting in cross progeny (nonDumpy offspring) were 
excluded from analysis.   All other crosses with recipient worms surviving to the end of 
the mating period were included, because no marker for successful mating is available for 
this assay.  To assess mating frequency in different fer-1 mutant strains, males were 
labeled with MitoTracker and incubated with hermaphrodites in 1:1 crosses.  
Hermaphrodites were then examined after 5 hr for the presence of labeled sperm.  This 
assay likely underestimates the total mating frequency in transactivation assays, since 1) 




period, and 2) a higher ratio of 4 males:1 hermaphrodite was used for transactivation 
assays. 
 
Assays of in vitro sperm activation 
Activation assays were performed essentially as in (Shakes and Ward, 1989).  
Adult virgin males were dissected to release sperm in a drop of SM on a glass slide; a 
chamber was formed over the cells using a coverslip supported by a thin layer of 
Vaseline; additional SM either with activator (200 µg/mL Pronase or 60 mM TEA) or 
without it (control) was wicked through this chamber; and the coverslip was completely 
sealed with Vaseline.  An image was obtained immediately upon wicking through 
activator and subsequent images were obtained every 5 min for at least 25 min.  
Activation was scored at each time point based on cell shape.  To obtain time-lapse 
videos, activation assays were performed as described except that images were obtained 
once per minute. 
 
Observation of TRY-5::GFP transfer 
For each trial, one to two 24 hr post-L4 Ptry-5::TRY-5::GFP; try-5(tm3813) him-
5 males were placed at the center of a circle of ten unc-52, unc-31 or unc-76 him-5 virgin 
adult hermaphrodites.  Males were observed for 10 min under transmitted light using a 
Leica MZ16FL microscope.  Prior to or shortly after spicule insertion occurred, the light 
source was switched to epifluorescence and images were collected at maximum speed (an 
exposure time of approximately 300 msec) using an AxioCam MRm (Zeiss) until 
spicules were removed.  If copulation was not attempted within 10 min, males were 





Standard molecular biology protocols were used (Sambrook et al., 1989).  RNA 
was extracted from mixed-stage him-5 worms using TRIzol (Invitrogen).  Reactions for 
5’- and 3’-RACE (rapid amplification of cDNA ends) were performed using GeneRacer 
(Invitrogen).  The MultiSite Gateway Three-fragment Vector Construction Kit 
(Invitrogen) with pCFJ150 as the destination vector (Frokjaer-Jensen et al., 2008) was 
used to generate MosSCI donor constructs (Tables 2.S1 and 2.S2).  Plasmid pCM1.35 
was a gift from G. Seydoux (Merritt et al., 2008).  For TRY-5::GFP, fusion PCR was 
performed as in (Hobert, 2002).  Details of Gateway plasmid construction are listed in 
Table 2.S1 and Table 2.S2.  To generate pJRS17, the 279 bp KpnI-XhoI fragment from 
pPD95.85 was ligated into the 4855 bp KpnI-XhoI fragment from pJRS11, thereby 
replacing the Ser65Cys variation present in GFP derived from pPD95.75 with the 
Ser65Thr variation from pPD95.85. 
 
Transgenic strains 
To generate transgenic strains harboring extrachromosomal arrays, constructs 
were injected (Mello et al., 1991) into the strain unc-119; swm-1(me86) try-5(jn2) him-5 
and transgenic lines were selected based on rescue of the Unc-119 phenotype (Frokjaer-
Jensen et al., 2008; Maduro and Pilgrim, 1995).  Single-copy insertion (MosSCI) strains 
were generated by the direct insertion technique into the Mos1 insertion site ttTi5605 as 
described by Frokjaer-Jensen (2008).  Targeting constructs were coinjected with Pglh-
2::transposase as the source of Mos transposase and coinjection markers labeling 
pharyngeal muscle (Pmyo-2::mCherry), body wall muscle (Pmyo-3::mCherry), and 




Quantification of spe-29 suppression 
 Single L4 hermaphrodites were placed on individual plates and transferred on day 
2, 4 and 6.  Dumpy self-progeny were counted once all worms had reached at least the L4 
stage.  Brood counts were performed on all strains in parallel.  Cases in which 
hermaphrodites died prior to the sixth day were excluded.  The spe-29 dpy-20; swm-1 try-
5 him-5 strain was maintained by trans-activation crosses in which swm-1 males were 





Figure 2.1.  Mutations in the serine protease gene try-5 suppress premature sperm 
activation in swm-1 mutant males.  Sperm activation was examined in staged 48 hr post-
L4 adult virgin males.  (A-D) Differential interference contrast (DIC) images showing 
sperm morphology in the indicated strains.  Top row: Images of intact males in the region 
of the seminal vesicle (SV), where sperm are stored.  Strains shown in A, C and D have 
round spermatids, which pack together in the SV of intact animals to form a uniformly 
grainy appearance.  The strain shown in B contains activated sperm, resulting in a rough 
appearance.  Arrowheads indicate the anterior (white) and posterior (black) boundaries of 
the SV.  Scale bar, 25 µm.  Bottom row:  DIC images of dissected sperm.  Arrow 
indicates a pseudopod.  Scale bar, 5 µm.  (See Figure 2.S1 for high-resolution versions of 
the images in B, C.)  (E) Schematic of the try-5 region.  We used RACE and RT-PCR to 
characterize try-5 transcripts, generating updated gene models as compared to the 
WormBase prediction ((WormBase); accession numbers JN651275, JN651276 and 
JN651277).  On gene models, darker shading indicates predicted coding regions and 
arrow indicates the direction of transcription.  The positions of mutations in try-5 are 
indicated along with their predicted effects.  (See also Figure 2.S2.)  (F) Quantitation of 
suppression of swm-1 by mutations in try-5.  Stacked columns indicate the percent of 
males containing either only activated sperm (black), a mixture of spermatids and 
activated sperm (hatched), or only nonactivated spermatids (grey).  At least 30 animals 
were scored for each genotype.  (G) A try-5 transgene restores sperm activation in swm-1 
mutant males.  Sperm activation was assayed in unc-119; swm-1(me86) try-5(jn2) him-5 
males bearing extrachromosomal arrays of pJRS14, which contains try-5(+) and C. 
briggsae unc-119(+) (Tables 2.S1 and 2.S2).  Data from three independent transgenic 
lines are shown.  Key for stacked columns as in (F).  Between 22 and 31 animals were 





























Figure 2.2.  try-5 mutant sperm are capable of activation.  Sperm were assayed for 
activation in response to protease treatment.  Wild-type or try-5(tm3813) mutant sperm 
were dissected and incubated in 200 µg/mL Pronase for 25 min; activation was scored 
every 5 min based on the presence or absence of a pseudopod.  (A) Maximal activation 
observed at a single time point during the assay; average of 3 repeats.  Error bars 
represent standard error of the mean.  (B,C) DIC images of try-5(tm3813) sperm prior to 
Pronase treatment (B) and the same field of cells at 20 min (C).  See also Video 
PronaseAct.  Arrows indicate the pseudopodia for two of the activated cells.  Scale bar, 













Figure 2.3.  try-5 is not required for fertility and functions in parallel to the spe-8 group.  
Hermaphrodite and/or male fertility was measured for try-5 mutant strains.  (A) try-5 
hermaphrodites show normal fertility.  Columns indicate average brood size of self-
fertilizing hermaphrodites.  Error bars represent standard error of the mean.  (B) try-5 
males show normal fertility.  Males were placed with spe-8(hc40); dpy-4 hermaphrodites 
in 1:1 crosses for 48 hr and the entire brood size was measured by counting the total 
number of nonDumpy cross progeny.  try-5 mutants were not significantly different from 
the control (try-5(jn2), p=0.95; try-5(tm3813), p=0.40; Mann-Whitney U Test).  (C) try-5 
is required for fertility in spe-8 group mutant males. Males were placed with spe-8(hc40); 
dpy-4 hermaphrodites in 1:1 crosses for 48 hr and the number of nonDumpy cross 
progeny produced during the mating period was counted.  Infertility of spe-8 group; try-5 
males was due to failure of sperm to activate or migrate (Table S4).  (B,C) Each point 
represents the result of an individual cross; gray lines represent medians.  Sets of crosses 
with each genotype were repeated at least twice and a representative set of data is shown.  












Figure 2.4.  TRY-5 is required for the activation of hermaphrodite sperm by male seminal 
fluid.  Transactivation was assayed for try-5 males.  L4 males were mated to L4 spe-
8(hc53); dpy-4 hermaphrodites in 4:1 crosses for 48 hr, and the number of Dumpy self-
progeny produced during the mating period was counted.  Each point represents the result 






Figure 2.5.  try-5 is expressed in the male somatic gonad.  Confocal and transmitted-light 
(TL) images of transgenic males bearing try-5 reporter insertions.  In TL images, 
boundaries of regions of the somatic gonad are labeled as sv, seminal vesicle; vl, valve; 
and vas, vas deferens.  Scale bars, 10 µm.  (A) jnSi49[Ptry-5::GFP::H2B]; try-
5(tm3813) L4 male.  In focal planes shown, GFP is visible in the four GFP-positive 
seminal vesicle cells, two of four GFP-positive valve cells, and six of twelve GFP-
positive cuboidal cells.  (B) jnSi62[Ptry-5::TRY-5::GFP]; try-5(tm3813) L4 male.  TRY-
5::GFP is concentrated at the apical side of seminal vesicle, valve and cuboidal cells.  (C) 
jnSi62[Ptry-5::TRY-5::GFP]; try-5(tm3813) 48 hr adult male. Both large and small 
TRY-5::GFP globules are present in the cuboidal cells and valve region. In the seminal 
vesicle, TRY-5::GFP is present in the proximal region near the valve.  (D) jnSi62[Ptry-
5::TRY-5::GFP]; swm-1(me87) try-5(tm3813) 48 hr adult male.  TRY-5::GFP has 
expanded into the seminal vesicle lumen and sperm are activated.  (C’, D’) Images of 
seminal vesicle regions outlined in C and D with intensity levels optimized for the fainter 
GFP signal in these tissues.  Arrows indicate GFP in the distal sheath-like cells of the 
seminal vesicle.  (E) Paired DIC, epifluorescence and merged images of a jnSi62[Ptry-
5::TRY-5::GFP]; try-5(tm3813) 72 hr adult male in the region of the seminal vesicle.  





















Figure 2.6.  TRY-5 is transferred to hermaphrodites during mating.  Selected still images 
(A-F) and schematics (A’-F’) depicting the time course of TRY-5::GFP transfer to an 
unc-52 hermaphrodite (see Video TRY5transfer).  (A) TRY-5::GFP is visible within its 
source cells in the valve (small bracket) and vas deferens (large bracket). (B) Transfer of 
TRY-5::GFP from the vas deferens into the hermaphrodite.  (C) Pause between transfer 
of the two pools.  (D, E) Transfer of TRY-5::GFP from the valve into the hermaphrodite.  
(F) Spread of TRY-5::GFP within the uterus concomitant with transfer of sperm (data not 
shown).  Arrows indicate TRY-5::GFP during transfer, “V” symbols indicate position of 
the hermaphrodite vulva, and arrowheads indicate TRY-5::GFP within the uterus.  Time 








Figure 2.7.  Models for the protease regulation of sperm activation in males and 
hermaphrodites.  (A) Model: Male pathway for sperm activation, shown prior to mating 
when SWM-1 inhibits TRY-5 activity within the male gonad to prevent premature 
activation.  In the absence of SWM-1, activation is signaled through interaction between 
TRY-5 and spermatids, likely through cleaving a target(s) on the cell surface (black 
arrows).  Potential targets of TRY-5 include both members of the SPE-8 group and one or 
more additional sperm surface proteins.  (B) Model: Hermaphrodite pathway for self-
sperm activation.  Activation is signaled through interaction between hermaphrodite 
activator and spermatids in the spermathecae (black arrow).  This process is dependent on 
activity of the SPE-8 group.  SWM-1 weakly antagonizes self-sperm activation, 
suggesting that the hermaphrodite activator may be a protease.  (C) Model: Pathways for 
activation after mating and seminal fluid transfer.  When mating occurs, components of 
male and hermaphrodite pathways are both present and can promote sperm activation. 
Either pathway can activate both male and hermaphrodite sperm (grey arrows).  











Figure 2.S1.  High-resolution images of adult males showing suppression of swm-
1(me87) premature sperm activation by try-5(tm3813).  (A and A’) swm-1(me87) male 
from Figure 2.1B.  Prematurely activated sperm within the seminal vesicle result in a 
disorganized appearance.  Arrows indicate a subset of individual spermatozoa for which 
pseudopods are visible.  (B and B’) swm-1(me87) try-5(tm3813) male from Figure 2.1C.  
Nonactivated spermatids, containing condensed nuclei and distinctive grainy cytoplasm, 
are present throughout the seminal vesicle.  Individual cell boundaries are often not 
visible by DIC; to convey packing together of these cells, arrowheads indicate the nuclei 





Figure 2.S2.  TRY-5 is a serine protease.  Alignment of TRY-5 with the serine proteases 
trypsin, chymotrypsin and elastase (accession numbers NP_002760, NP_001897, and 
NP_031378).  The signal sequence was predicted for TRY-5 using SignalP 3.0 (Bendtsen 
et al., 2004).  Positions of try-5 alleles are shown.  Shading corresponds to identities 
(black) or similarities (grey) among two or more family members.  Arrows indicate 














Figure 2.S3.  swm-1 try-5 double mutant hermaphrodites and males are fertile.   Assays of 
hermaphrodite self-fertility and male fertility.  (A) swm-1 try-5 double mutant 
hermaphrodites have wild-type fertility levels.  Columns indicate average brood size of 
self-fertilizing hermaphrodites.  Error bars represent standard error of the mean. (B)  
swm-1 try-5 males have improved fertility as compared to swm-1 males.  Although the 
fertility of double mutants was always significantly higher than that of swm-1, variable 
levels of suppression were observed for the swm-1 try-5(tm3813) strain.  The results of 
two representative experiments are shown.  Each point represents the result of an 
individual cross; gray lines represent medians.  For Repeat 1, swm-1 try-5(tm3813) 
fertility did not differ from that of wild-type males (p=0.67, Mann-Whitney U Test), a 
result obtained twice.  For Repeat 2, swm-1 try-5(tm3813) fertility did differ from that of 
wild-type males (p=0.003, Mann-Whitney U Test), a result that was also obtained twice.  
For both repeats, swm-1 try-5(jn2) fertility did not differ from that of wild-type males 












Figure 2.S4.  try-5 activity is not required in hermaphrodites for suppression of spe-29 
sterility by swm-1.  Assay of hermaphrodite self-fertility.  Total self-progeny broods from 
individual hermaphrodites were counted for each strain (Protocol S1).  Each point 
represents the total self-progeny from an individual hermaphrodite; lines indicate the 
median for each set.  Three replicates of the experiment were performed, with equivalent 
results; data from one such replicate are shown.  spe-29; swm-1 and spe-29; swm-1 try-5 
hermaphrodite fertility were each significantly different when compared to spe-29 
fertility (p<10
-6
, Mann-Whitney U test).  Their fertility was not significantly different 
when compared to each other (p=0.65).  In addition to the listed genotypes, all strains 












Table 2.1.  TRY-5 is not required for activation in spe-6 animals. 
Genotype1 % Act2 n 
wild type 97 32 
spe-6(hc163) 100 40 
try-5(jn2) 0 43 
try-5(tm3813) 0 53 
spe-6(hc163); try-5(jn2) 100 42 
spe-6(hc163); try-5(tm3813) 100 61 
 
1
All strains also contained the mutation dpy-18(e364). 
2







Table 2.S1. Primers used for construction of Gateway Donor plasmids. 
Plasmid Fragment description Length Gateway vector Forward primer1 Reverse primer1 


























 1892 bp NA AGCTTGCATGCCTGCAGGTCG AAGGGCCCGTACGGCCGACTA 
 
1
 For primers, lower-case type indicates spacer and att site sequences; upper-case type indicates gene-specific sequences.  
Genomic him-5 DNA was used as a template unless noted.   
2
 To generate the try-5::GFP(S65C) construct pJRS11, fusion PCR was performed using the 1631bp try-5 and 1892bp GFP 
fragments listed.   
3
 NA, not applicable. 
4











Table 2.S2.  Donor plasmids used for construction of destination constructs. 
Plasmid Description Position 1 Position 21 Position 3 Vector2 
pJRS14 Ptry-5::try-5::try-5 3’ UTR pJRS13 pJRS7 pJRS8 pCFJ150 
pJRS18 Ptry-5::try-5::GFP(S65T)::try-5 3’ UTR pJRS13 pJRS17 pJRS8 pCFJ150 
pJRS22 Ptry-5::GFP::H2B::try-5 3’ UTR pJRS13 pCM1.35 pJRS8 pCFJ150 
 
1 
Plasmid pCM1.35 was a gift of of G.Seydoux (Merritt et al., 2008).   
2 









Table 2.S3.  Premature sperm activation depends on TRY-5 and SWM-1 and increases 




Age1 nonAct partAct fullAct 
 
Total 
Wild type 24hr 56 0 0 56 
 48hr 47 0 0 47 
 72hr 51 5 1 57 
swm-1(me87) 24hr 1 1 51 53 
 48hr 0 0 49 49 
 72hr 0 1 52 53 
try-5(tm3813) 24hr 53 0 0 53 
 48hr 44 0 0 44 
 72hr 72 0 0 72 
swm-1(me87) try-5(tm3813) 24hr 53 0 0 53 
 48hr 50 0 0 50 
 72hr 51 0 0 51 
jnSi62[Ptry-5::TRY-5::GFP]; 
try-5(tm3813) 24hr 55 0 0 55 
 48hr 51 0 0 51 
 72hr 120 4 0 124 
jnSi62[Ptry-5::TRY-5::GFP]; 
swm-1(me87) try-5(tm3813) 24hr 22 11 9 42 
 48hr 0 0 54 54 
 72hr 0 0 67 67 
 
1
L4 larval stage males were isolated from hermaphrodites and incubated at 20C for the 












Table 2.S4.  spe-8 group; try-5 sperm do not migrate after transfer to a hermaphrodite. 
Genotype Total crosses No. transfer1 No. migration2 
spe-27 45 21 12 
spe-27; try-5(tm3813) 42 19   0 
spe-29 50 34 32 
spe-29; try-5(tm3813) 50 35   1 
 
1
Number of crosses in which MitoTracker-labeled sperm were observed inside recipients. 
2
















around cells in 


























::GFP]; try-5(tm3813) 24hr 5 0 0 50 0 0 0 0 0 55 
 48hr 25 0 0 26 0 0 0 0 0 51 
 72hr 43 0 0 75 0 0 2 4 0 124 
jnSi62[Ptry-5::TRY-5 
::GFP]; swm-1(me87) 
try-5(tm3813) 24hr 12 0 0 10 2 0 0 9 9 42 
 48hr 0 0 0 0 0 0 0 0 54 54 
 72hr 0 0 0 0 0 0 0 0 67 67 
 
1
No TRY-5::GFP was visible adjacent to sperm cells in the seminal vesicle lumen. 
2
Discrete foci of TRY-5::GFP were observed adjacent to sperm cells within the seminal vesicle lumen. 
3
Areas of TRY-5::GFP were present in a dispersed honeycomb-like pattern surrounding sperm cells in the seminal vesicle lumen. 
4
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 Seminal fluid contains many proteins, which are predicted to have varying 
activities.  For these proteins to affect sperm function, they need to enter the seminal fluid 
by secretion from neighboring tissues.  Secretion of proteins into seminal fluid occurs by 
a variety of methods.  Proteins can be secreted directly into the seminal fluid as soluble 
proteins prior to mating.  This secretion occurs in the seminal vesicle, epididymis, and 
prostate.  For example, HE1/CTP transports hydrophobic compounds such as cholesterol 
in the seminal fluid to sperm (Kirchhoff et al., 1996).  Another important group of 
seminal fluid proteins are the semenogelins, which form seminal clots after mating that 
restrict sperm movement (Lilja and Lundwall, 1992).  Other factors are secreted only 
after mating begins and may have roles only during the process of mating.  One such 
protease is prostate specific antigen (PSA), which is secreted from the prostate and added 
to seminal fluid during mating (reviewed in Veveris-Lowe et al., 2007).
 As an alternative to direct secretion, seminal fluid components may be transferred 
in small, 50-500 nm vesicles that are called exosomes.  Exosomes can be secreted from 
several tissues.  Within the male reproductive tissues, exosomes are secreted from the 
epididymis (epididymosomes) and the prostate (prostasomes) (reviewed in Saez et al., 




the sperm membrane, altering the components on the cell surface, and thus sperm 
function.  In the cases where prostasomes remain unfused, no precise function is known.  
However, prostasomes are thought to have roles in multiple processes, including 
modulating immune responses, capacitation, and providing antioxidant protection 
(reviewed in Sullivan et al., 2005). 
 In TRY-5::GFP expressing male worms, I found that TRY-5 is secreted from 
several tissues of the somatic gonad.  Transfer occurs in a series of discrete steps and 
always occurs in the same order.  First, TRY-5 from the vas deferens is transferred.  A 
brief pause in TRY-5 transfer occurs before TRY-5 from the valve region is transferred.  
The valve pool of TRY-5 is immediately followed by sperm transfer (Smith and 
Stanfield, 2011).  The mechanisms for how TRY-5 is transferred in such an ordered 
fashion are unknown. 
 In this chapter, I focus on the secretion of TRY-5.  I describe additional try-5 
alleles that suggest TRY-5 secretion in swm-1 mutant males and during mating may 
occur through different processes, and I explore the expression and transfer of TRY-5 in 
more detail.  These results suggest that TRY-5 release is dependent on a secretion signal 
and may originate in vesicles of the valve region. 
 
Results 
jn13 and jn21 Swm-1 phenotype suppression 
 A nonsense mutation, jn13, in which the last 20 amino acids of the TRY-5 protein 
are not translated, was identified in a screen for suppressors of the premature sperm 
activation phenotype in males with the partial loss-of-function allele of swm-1, me86 (A. 




suppressed the Swm-1 premature sperm activation phenotype (Smith and Stanfield, 
2011).  In addition, jn21, a mutation in the start codon of try-5, was identified in a 
premature sperm activation phenotype suppressor screen using males with a different 
partial loss-of-function allele of swm-1, me66 (B. Duffy, and A. Duffy, personal 
communication).  I examined the suppression of the Swm-1 premature sperm activation 
phenotype.  I found that while all swm-1(me66) virgin males contained activated sperm 
48 hr after the L4 stage, 60% of swm-1(me66) try-5(jn21) males did not contain activated 
sperm.  Of the remaining 40% of males, about half contained activated sperm and the 
other half contained a mix of spermatids and spermatozoa (Smith and Stanfield, 2011).  
Since suppression is not complete, jn21  represents a likely partial loss-of-function allele. 
 
Timing and temperature sensitivity 
of activation in try-5(jn2) males 
 Male sperm activates earlier at higher temperatures (G. Stanfield, personal 
communication).  I tested if try-5 mutant male sperm activated at higher temperatures 
than the standard maintenance temperature of 20°C (Figure 3.1).  I used the jn2 allele of 
try-5, since it is a mutation in a conserved cysteine and is a likely null (Smith and 
Stanfield, 2011).  At 24 hr, 48 hr, and 72 hr after the L4 stage and at 15°C, 20°C, and 
25°C for each time point, fewer swm-1(me86) try-5(jn2) males than either the wild-type 
control or the swm-1(me86) control contained activated sperm.  This result suggests that 
while try-5 is necessary for efficient activation in swm-1 mutants, activation can still 
occur, although at a slower rate.  Alternatively, jn2 may be a partial loss-of-function 





Time course of TRY-5::GFP expression 
 To learn more about the regulation of try-5 expression and timing of expression, I 
examined the pattern of TRY-5::GFP localization in four independent Ptry-5::TRY-
5::GFP extrachromosomal array lines in unc-119; swm-1(me86) try-5(tm3813) males.  I 
found that expression started during the L4 stage in the vas deferens.  Expression was 
observed in the valve region 4 to 9 hours later.  TRY-5::GFP was observed initially only 
within the tissues of expression; however, beginning between 12 and 25 hr after L4, 
TRY-5::GFP was observed to spread into the lumen of the seminal vesicle (data not 
shown).  The source of this TRY-5::GFP was not determined and activation was not 
scored for these worms.  These results show that while TRY-5::GFP is present within the 
seminal vesicle starting at 48 hr after the L4 stage, prior to that time, TRY-5::GFP may 
only be in or immediately adjacent to the cells of expression.   
 
Tissue specific rescue of try-5 
 TRY-5::GFP expression was previously observed in neurons in Ptry-5::TRY-
5::GFP strains in which the transgene was stably inserted using the MosSCI technique 
(Mos1-mediated Single Copy gene Insertion) (Frokjaer-Jensen et al., 2008; Smith and 
Stanfield, 2011).  I sought to determine if try-5 expression in tissues other than the 
somatic gonad is sufficient for the rescue of the try-5 phenotype, or if expression in the 
somatic gonad is necessary for rescue of the try-5 phenotype.  I generated transgenic 
worms with Prab-3::TRY-5::GFP (neuronal) and PC49C3.12::TRY-5::GFP (vas 
deferens) transgenes stably inserted.  When present in a try-5(tm3813) mutant 
background, virgin adult males did not contain activated sperm, similar to Ptry-5::TRY-




background, sperm activation did occur in males with neuronally expressed TRY-5::GFP 
at a rate similar to that of Ptry-5::TRY-5::GFP males (Figure 3.2).  In males containing 
activated sperm, GFP was not visible within the seminal vesicle.  In PC49C3.12::TRY-
5::GFP males, fewer than 10% of virgin adult males aged 48 hr after the L4 stage 
contained activated sperm (Figure 3.2).  To determine if activation was time dependent, I 
also scored these males 72 hr after the L4 stage.  I found that the older males more 
frequently had activated sperm, but this level of rescue was lower than that of Ptry-
5::TRY-5::GFP or Prab-3::TRY-5::GFP males.  These results show that expression of 
TRY-5 in neurons, but not the seminal vesicle, can rescue sperm activation in a swm-1 
mutant background.  While TRY-5 expression in neurons may rescue sperm activation, 
whether TRY-5 enters the seminal vesicle and signals sperm activation directly is 
unknown. 
 
Transactivation is not rescued by TRY-5::GFP expression 
in the somatic gonad or neurons 
 try-5 has been shown to be necessary for activation in two different cases.  One 
case is activation of sperm in swm-1 males.  Sperm activation has been rescued with a 
stable insertion of Ptry-5::TRY-5::GFP in swm-1 try-5 mutant backgrounds (Smith and 
Stanfield, 2011).  The other case is transfer of the male activator, as measured by 
transactivation of spe-8 mutant hermaphrodite sperm.  To show that try-5 is necessary for 
transactivation, I expressed try-5 in a fer-1 mutant background, using the same transgene 
that rescues premature sperm activation.  Despite observations that TRY-5::GFP can be 
transferred to hermaphrodites during mating, this transgene does not rescue 




observed; however, the number of self-progeny was not different when compared to that 
of the no mating (P=0.76, Mann-Whitney U Test) and fer-1; try-5 (P=0.15, Mann-
Whitney U Test) controls.  However, 3 out of 22 crosses did produce more self-progeny 
than produced in any of the no male controls.  Lack of rescue was confirmed in an 
additional two lines (A. Hansen, personal communication), although infrequent 
transactivation did occur after mating with males from these two lines.  Overall, the Ptry-
5::TRY-5::GFP transgene does not efficiently rescue the transactivation defect. 
 To test whether expression in other tissues is sufficient for transactivation, I 
expressed TRY-5::GFP in neurons (Prab-3::TRY-5::GFP) and the vas deferens 
(PC49C3.12::TRY-5::GFP) in a fer-1 mutant background.  Upon mating to spe-8 mutant 
hermaphrodites, fer-1; Prab-3::TRY-5::GFP; try-5(tm3813) males did not transactivate 
spe-8 mutant hermaphrodite sperm (Figure 3.3).  fer-1; PC49C3.12::TRY-5::GFP; try-
5(tm3813) male transactivation was similar to that of fer-1; Ptry-5::TRY-5::GFP; try-
5(tm3813) transactivation (P=0.15, Mann-Whitney U Test) (Figure 3.3).  Transactivation 
was observed in 5 of 13 crosses performed, although few self-progeny were produced in 
each case.  I confirmed that TRY-5::GFP expression occurred at 25°C by examining 
males at the beginning and end points of the experiment and saw expression similar to 
that of males grown at 20°C (data not shown).  These results suggest that transactivation 
cannot be rescued by expression of TRY-5::GFP, which may be due to the necessity of a 
high level of TRY-5 transfer for transactivation to occur.  To test if GFP interferes with 
TRY-5 function, I generated a line consisting of a Ptry-5::TRY-5 stable insertion in a fer-
1; try-5(tm3813) him-5 background.  I found that these males were not capable of 




rescuing try-5 suppression of the Swm-1 premature sperm activation phenotype and only 
one line has been tested for rescue of the transactivation defect. 
 
Transactivation is deficient in try-5 transheterozygotes 
 Since transgene rescue of the Try-5 transactivation defect was unsuccessful, 
mutations in try-5 may not be the cause of the transactivation defect, and instead another 
background mutation might be responsible for this phenotype.  To test whether mutations 
in try-5 result in a transactivation defect, I determined if try-5 mutant transheterozygotes 
were able to transactivate spe-8 hermaphrodite sperm.  If the transactivation defect 
remains in try-5 transheterozygotes, then background mutations are unlikely to be the 
causal mutations for the transactivation phenotype.  I tested the jn2 and tm3813 alleles, 
since both of these mutations are likely nulls and were produced in different labs, and 
thus they were likely to have different background mutations.  try-5 heterozygous mutant 
males appeared to transactivate fewer spe-8 mutant hermaphrodite sperm and induced 
transactivation less frequently than the fer-1 control (Figure 3.4).  The try-5 
transheterozygotes do not transactivate spe-8 hermaphrodite sperm, which is similar to 
that of try-5(jn2) and try-5(tm3813) homozygous males.  Since a temperature-sensitive 
allele of fer-1 was used, cross progeny occasionally resulted from crosses.  Cases in 
which cross progeny were produced were removed from analysis, since sperm 
competition could have reduced the number of self-progeny produced.  Removal of these 
crosses from analysis resulted in a relatively small data set.  In addition, mating was not 
confirmed for the transheterozygotes, although homozygotes for both alleles of try-5 have 
been confirmed to mate.  The reduced transactivation by heterozygous try-5 mutants 




the male.  These results suggest that try-5 is necessary for transactivation, and the 
phenotype is not a result of a background mutation. 
 
Males with partial loss-of-function alleles 
of try-5 have defects in transactivation 
 Using the transactivation assay, I could test if jn13 and jn21 were indeed partial 
loss-of-function alleles of try-5.  Since try-5 is only 0.1 map unit from swm-1, I had not 
separated the swm-1 and try-5 mutations for either try-5 allele.  Instead, I tested fer-1; 
swm-1(me86) males and fer-1; swm-1(me86) try-5(jn13) males for their ability to 
transactivate spe-8 hermaphrodite sperm (Figure 3.5A).  I found that fer-1; swm-1(me86) 
males were able to transactivate sperm infrequently, and at levels greater than that of fer-
1; try-5(tm3813) males (P=0.08, Mann-Whitney U Test).  Transactivation of spe-8 
hermaphrodite sperm occurred very infrequently (4 crosses out of 134 performed) after 
mating with fer-1; swm-1(me86) try-5(jn13) males (Figure 3.5A and data not shown).  
While fer-1 and fer-1; swm-1(me66) males were capable of transactivation of spe-8 
hermaphrodite sperm, fer-1; swm-1(me66) try-5(jn21) males never transactivated spe-8 
hermaphrodite sperm (Figure 3.5B).  I found no transactivation even in three rounds of 
setting up 25 crosses each.  These results suggest that jn21 is a partial loss-of-function 
allele of try-5 based on partial suppression of the Swm-1 premature activation phenotype, 
but is not capable of transactivation.  The jn13 allele results suggest that it may be a null 
allele.  However, the occasional transactivation observed suggests that jn13 may be a 






Higher resolution imaging of TRY-5::GFP transfer 
 Transfer of TRY-5::GFP has been described previously (Smith and Stanfield, 
2011); however, spatial and temporal resolution was limited due to the techniques used.  
A compound microscope subsequently was used to decrease exposure times and increase 
resolution.  I found that exposure to the level of light necessary for GFP imaging 
disturbed mating.  Males appeared to stop the process of mating and would attempt to 
crawl away, as has been previously described in response to blue light (Edwards et al., 
2008).  I did observe one successful case of mating (Figure 3.6).  TRY-5::GFP was 
present at the tip of the male tail prior to imaging, thus vas deferens TRY-5::GFP transfer 
already may have occurred.  The valve TRY-5::GFP transfer appeared similar to previous 
observation, including the timing, amount transferred, that a single pool was transferred, 
and spread to a similar extent once in the hermaphrodite.  However, the male did not 
successfully terminate mating by removing his spicules from the hermaphrodite, which 
suggests other aspects of mating may be disturbed.  In the valve region, only a fraction of 
TRY-5::GFP appeared to be released.  Shortly before release, TRY-5::GFP appeared to 
form small foci similar in size to vesicle-like structures seen in the valve region prior to 
mating.  Remaining TRY-5::GFP in the valve region also appeared to be in vesicle-like 
structures that appeared to be in cells of the valve region.  These results suggest that 
membrane-bound TRY-5 may be transferred during mating.  Membrane transfer from the 
vas deferens has been suggested based on transfer of GFP by males expressing 
PC49C3.12::memGFP (data not shown).  In this case, a membrane-localization signal 
was fused to GFP, thus the GFP present in the hermaphrodite after mating likely was 





 try-5 expression appears to begin early during the L4 stage.  Expression initially 
starts in a few cells of the vas deferens and expands to the valve region and seminal 
vesicle as the males age.  During adulthood, expression of try-5 appears to continue, 
since GFP continually becomes brighter until at least 75 hr after the L4 stage.  Expression 
occurs in the three different tissues by early adulthood, with expression seen in the valve 
region and vas deferens.  These results show that TRY-5 is expressed before the male is 
capable of mating.  Expression continues through adulthood, allowing for a high level of 
TRY-5 protein to be present during mating.  Also, TRY-5 may be replenished after 
mating by the continued expression; however, the recovery of TRY-5 after mating has 
not been analyzed.  For the time course, the TRY-5::GFP transgene was present on an 
extrachromosomal array, and as a result an unusually high level of expression may have 
occurred.  A higher level of expression may not accurately replicate the endogenous 
expression of TRY-5.  Additionally, mosaicism may occur, since the array can be lost.  
To control for these cases, multiple lines were examined and a similar pattern of 
expression was found in each line.  Finally, the experiment was performed under a 
dissecting microscope, which allowed for observation of the same worms at multiple 
times.  However, a higher level of GFP is required to see expression.  As a result, areas of 
low expression may not be visible. 
 In Ptry-5::TRY-5::GFP and Ptry-5::GFP::H2B transgenic males, GFP was 
observed in a small number of neurons within the tail and near the pharynx of the worm, 
both when expressed from extrachromosomal arrays and MosSCI insertions.  To 




expressed TRY-5 in neurons and observed that sperm activation occurred in a swm-1 
mutant background.  This result shows that TRY-5 expression in neurons can result in 
activation.  Two models of how this activation occurs are possible.  First, TRY-5 within 
neurons is necessary for the signaling of activation.  Alternatively, TRY-5 is secreted 
from neurons and able to enter the seminal vesicle to signal sperm activation in a process 
that does not replicate endogenous sperm activation.  While TRY-5::GFP was not 
observed in the lumen of seminal vesicles, expression was observed adjacent to cells of 
the seminal vesicle.  Since TRY-5 is likely to function as a protease, cell-cell contacts 
may be disturbed by proteolytic cleavage of proteins necessary to maintain cell-cell 
adhesion, allowing for TRY-5 to enter the seminal vesicle in low concentrations, which 
would not be easily observable.  This model would require that TRY-5 is able to signal 
sperm activation at a low concentration within the male.  Additional expression in other 
somatic tissues needs to be performed in the future to determine if secretion from 
anywhere outside of the somatic gonad can signal sperm activation in males. 
 To test whether the mutations I have identified in try-5 are responsible for the 
transactivation defect phenotype, I tried to rescue the defect using a known functional 
TRY-5::GFP transgene.  Surprisingly, I found that only a low level of transactivation 
occurred.  I confirmed that TRY-5::GFP is expressed at the experiment temperature.  I 
observed that a low level of transactivation also occurred after mating with males that had 
a PC49C3.12::TRY-5::GFP transgene, which expresses TRY-5::GFP in the vas deferens.  
However, this transactivation did not occur after mating with Prab-3::TRY-5::GFP 
transgenic males.  These results suggest that TRY-5::GFP expressed within the somatic 




TRY-5::GFP is expressed in neurons, the level of transactivation is likely due to the 
expression of TRY-5::GFP in the vas deferens and also potentially the valve region.  
However, the low level of transactivation observed may be due to several complications 
inherent in this experiment.  TRY-5::GFP must be secreted and transferred in sufficient 
levels to signal sperm activation in hermaphrodites.  Any reduction in TRY-5 expression 
compared to endogenous TRY-5 expression or reduction in transfer of TRY-5 may 
reduce the concentration of TRY-5 within the hermaphrodite after transfer to levels 
below that which is necessary to signal activation.  Furthermore, the TRY-5::GFP fusion 
may have reduced activity if GFP interferes with activity of the protease domain. 
 Since the try-5 transactivation defect phenotype could not be strongly rescued by 
a transgene, I tested males mutant for different alleles of try-5 for transactivation.  I have 
found that males mutant for all alleles of try-5 do have the same transactivation defect 
phenotype.  To further show that the mutations in try-5 are likely causal for this 
phenotype and not another background mutation, I tested try-5 transheterozygotes for 
transactivation.  I found that transheterozygotes could not activate spe-8 mutant 
hermaphrodite sperm.  These results suggest that the try-5 mutation is responsible for the 
transactivation defect.  The likelihood of try-5 being necessary for transactivation is made 
stronger by the jn2 and tm3813 alleles being produced in independent labs.  Independent 
production of these alleles reduces the number of background mutations theses two 
strains would have in common.  By analyzing transheterozygotes, these background 
mutations are likely to be heterozygous and thus not causal for the elimination of 




 I tested try-5(jn13) using a transactivation assay to determine if jn13 is a partial 
loss-of-function allele of try-5.  I found that a low level of transactivation of spe-8 
hermaphrodite sperm did occur after mating with these males, based on the frequency of 
self-progeny produced after mating.  However, this transactivation was not significantly 
different from that of the no male control.  This result suggests that residual function of 
the TRY-5 protein does remain.  While jn13 appears to be a null of try-5, the infrequent 
transactivation observed suggests it may not be. 
 In addition, I observed that swm-1(me86) males are less capable of transactivation 
than wild-type males.  This result was surprising, as TRY-5 function is expected to still 
be present in the male, since sperm activation still occurs within the male and the screen 
which identified swm-1 was depended on mutants being capable of transactivation 
(Stanfield and Villeneuve, 2006).  In swm-1 mutant males, I observed that TRY-5 is more 
broadly localized, appearing to fill the lumens of the vas deferens and seminal vesicle.  
This localization may result in a lower concentration of TRY-5 that is not sufficient to 
signal sperm activation, since broader localization of TRY-5 may be less efficiently 
transferred than when TRY-5 is released from somatic gonad tissues during mating.  To 
differentiate between these possibilities, observations of TRY-5 transfer from swm-1 
mutant males need to be made to determine how much TRY-5 is transferred.  In addition, 
a better understanding of how SWM-1 and TRY-5 interact may reveal whether TRY-5 is 
degraded in the absence of SWM-1. 
 I found that the jn21 allele of try-5 only partially suppressed the swm-1 premature 
sperm activation phenotype.  This observation suggests that jn21 is a partial loss-of-




transactivation.  This differs from the other likely potential partial loss-of-function allele 
of try-5, jn13, which does occasionally transactivate spe-8 sperm.  These results suggest 
that jn21 may affect a different aspect of TRY-5 function than jn13.  jn21 alters the 
translational start site of TRY-5.  Since TRY-5 activity is still present, based on the 
partial suppression of the swm-1 phenotype, TRY-5 likely is translated, starting from a 
different translational start site.  By starting at a different site, the secretion signal may be 
removed, while maintaining the protease domain.  Several proteins, such as expression of 
a membrane-localization signal GFP fusion, ectopically expressed in the somatic gonad 
will still localize to secretory structures (A. Snow, personal communication).  This 
suggests that a secretion signal may not be necessary for secretion to occur from the 
somatic gonad.  Thus TRY-5 without a secretion signal may still be released from the 
somatic gonad, but perhaps at a lower level.  If a low level of protease is sufficient for 
sperm activation in a swm-1 mutant, but a high level is necessary for transactivation to 
occur, then this model would explain the phenotype seen.  To confirm that this is the 
case, the localization and dynamics of TRY-5 prior to and during mating would need to 
be determined.  A TRY-5::GFP construct that includes the jn21 mutation would allow for 
such observations.  Understanding how TRY-5 is secreted from the somatic gonad could 
allow for a better understanding of the regulation of secretion from the vas deferens and 
valve region. 
 Initial experiments to examine the process of TRY-5::GFP transfer to 
hermaphrodites during mating were performed using a dissecting microscope, which 
limited the resolution such that subcellular localization within cells could not be 




subset of the TRY-5::GFP pool within the valve region was transferred to hermaphrodites 
during mating.  Upon further examination of images previously taken on the dissecting 
microscope, partial transfer does not appear to be a result of the imaging method, and 
instead is common amongst males tested.  TRY-5::GFP that was transferred appeared to 
be from the apical side of the valve region.  Whether this pool is intracellular has not 
been determined.  Thus, two models of TRY-5::GFP transfer from the valve region can 
be proposed.  One model is that TRY-5::GFP is secreted shortly after it is expressed.  
This pool may remain in the valve region either by creating barriers to diffusion or by a 
lack of flow within the lumen of the somatic gonad.  The latter model could also be true 
if TRY-5::GFP release occurred shortly before the beginning of observations, thus not 
allowing enough time for it to spread within the somatic gonad.  The other model is that 
TRY-5 is secreted only after mating has occurred.  By further observing the process of 
TRY-5::GFP transfer, support for one of these two models may be found.  More detail 
may be observable by using lite-1 mutants, which do not respond to exposure of blue 
light (Edwards et al., 2008). 
 Overall, TRY-5 and seminal fluid secretion remains poorly understood with many 
remaining questions.  Mechanisms for regulating secretion, especially how timing is 
accomplished, are not understood.  Furthermore, how seminal fluid could be quickly 
released is not understood.  Since TRY-5 represents only the second seminal fluid protein 
identified in C. elegans, whether most seminal fluid proteins are expressed in the same 
tissues and secreted simultaneously as TRY-5 is not known.  Despite the remaining 
questions, identification of TRY-5 and understanding how its secretion is regulated may 





Materials and methods 
C. elegans genetics 
 Worms were maintained at 20°C as described in Brenner (1974) unless otherwise 
mentioned.  him-5(e1490) worms were used as the wild type to ensure a ready supply of 
males and always present in male stocks (Hodgkin et al., 1979).  Alleles used in this 
study were: spe-8(hc53) I (Wood and The Community of C. elegans Researchers, 1988), 
fer-1(hc1ts) I (Wood and The Community of C. elegans Researchers, 1988), unc-
119(ed3) III (Maduro and Pilgrim, 1995), dpy-4(e1166) IV (Wood and The Community 
of C. elegans Researchers, 1988), unc-31(e169) IV (Wood and The Community of C. 
elegans Researchers, 1988), swm-1(me66, me86, me87) V (Stanfield and Villeneuve, 
2006), and try-5(jn2, jn13, jn21, tm3813) V (Smith and Stanfield, 2011). 
 
Temperature and time course of suppression 
 L4 hermaphrodites were moved to plates placed at 15°C, 20°C, or 25°C.  Males 
from subsequent generations were picked as L4s onto plates without hermaphrodites and 
scored 24, 48, or 72 hr later.  At least 28 worms were observed at each time point and 
temperature combination. 
 
Tissue specific rescue 
 Gateway MosSCI constructs were prepared as described previously (Smith and 
Stanfield, 2011).  Prab-3 was from pEGB05, which was a gift of the Jorgensen lab 
(Hobson et al., 2011).  PC49C3.12 (Thoemke et al., 2005) was prepared using primers 
GGGGACAACTTTGTATAGAAAAGTTGagcctcattcatcgctgcgtcagtg and 




worms and recombined into the pDONR P4-P1r vector (Invitrogen).  The 3’ UTR used 
was the try-5 3’UTR from plasmid pJRS8 (Smith and Stanfield, 2011).  Injections into 
ttTi5605; unc-119(ed3) worms were performed as previously described (Frokjaer-Jensen 
et al., 2008).  Scoring was performed in the indicated backgrounds.  Transactivation 
assays were performed as previously described (Smith and Stanfield, 2011).  
Transactivation experiments were repeated at least three times each with 25-40 crosses 
performed each repeat mating four males to one spe-8(hc53); dpy-4 hermaphrodite.  




 Transheterozygous males were generated by crossing fer-1; try-5 him-5 males 
grown at 20°C to fer-1; him-5 or fer-1; try-5 him-5 hermaphrodites that were grown at 
25°C, so that only cross progeny would result.  The crosses were performed at 25°C.  
Males were picked and grown at 25°C and transactivation assays were performed as 
described previously (Smith and Stanfield, 2011). 
 
Time course of TRY-5::GFP expression 
 I generated four independent extrachromosomal array lines consisting of a Ptry-
5::TRY-5::GFP, Cbr-unc-119(+) array in a unc-119(ed3); swm-1(me86) try-5(tm3813) 
background (Maduro and Pilgrim, 1995).  I picked five L4 males from each of two 
independent extrachromosomal array lines and ten L4 males from each of the other two 
independent lines to individual plates.  I observed regions of TRY-5::GFP localization on 




min, 3 hr 30 min, 5 hr 30 min, 8 hr 30 min, 11 hr 30 min, 24 hr 30 min, 36 hr, 48 hr, 60 
hr, and 75 hr after picking.   
 
Transfer of TRY-5::GFP 
 Mating was performed on 30 mm NGM plates without bacteria.  One or two 
jnSi62[Ptry-5::TRY-5::GFP]; try-5(tm3813) males aged 24 hr after the L4 stage were 
mated to eight unc-31(e169) aged 24 hr after the L4 stage.  Male movement was observed 
under DIC using minimal light under a 10X objective using an AxioImager M1 (Zeiss) 
microscope.  Once a male made contact with a hermaphrodite, male mating behaviors 
were observed under a 20X objective until the male found the vulva, at which point 
recording of GFP images began.  Exposure was 200 ms at maximal speed, acquired with 
an AxioCam MRm (Zeiss) camera. 
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Figure 3.1.  Sperm activation is time and temperature sensitive.  Wild-type, swm-
1(me86), and swm-1(me86) try-5(jn2) males were examined for sperm activation 24 hr, 
48 hr, or 72 hr after the L4 stage.  For each genotype and time point, males were also 
scored for activation at 15°C, 20°C, or 25°C.  Males were scored as containing only 
nonactivated sperm (gray bars), containing a mixture of activated and nonactivated sperm 
(hatched bars), or containing only activated sperm (black bars).  At least 28 males were 
examined for each condition.  All strains also contained the him-5(e1490) mutation to 









Figure 3.2.  Activation of sperm in a swm-1 try-5 mutant background can be rescued by 
expression of TRY-5 in several different tissues.  TRY-5::GFP was expressed using 
different tissue-specific promoters: Ptry-5 (vas deferens, valve region, seminal vesicle, 
and some neurons), Prab-3 (neurons), and PC49C3.12 (vas deferens).  Activation was 
assessed in try-5(tm3813) and swm-1(me87) try-5(tm3813) backgrounds.  Males were 
scored as containing only nonactivated sperm (gray bars), containing a mixture of 
activated and nonactivated sperm (hatched bars), or containing only activated sperm 
(black bars).  At least 36 males were examined for each condition.  All strains also 








Figure 3.3.  Transactivation by try-5 mutant males cannot be efficiently rescued by 
transgenic expression of TRY-5::GFP.  L4 males expressing TRY-5::GFP or TRY-5 
under the endogenous try-5 promoter, the rab-3 neuronal promoter, or C49C3.12 vas 
deferens promoter were mated 4:1 with L4 spe-8(hc53); dpy-4 hermaphrodites for 48 hr.  









Figure 3.4.  try-5 transheterozygous males are not capable of transactivation.  L4 males 
that were heterozygous for either the jn2 or tm3813 allele of try-5 and transheterozygotes 
were mated 4:1 with L4 spe-8(hc53); dpy-4 hermaphrodites for 48 hr.  The number of 





Figure 3.5.  Transactivation by partial loss-of-function alleles of try-5.  try-5(jn13) males 
transactivate spe-8 hermaphrodite sperm infrequently and produces few self-progeny.  
try-5(jn21) males do not transactivate spe-8 hermaphrodite sperm.  L4 males that had the 
jn13 (A) or jn21 (B) allele of try-5 were mated 4:1 with L4 spe-8(hc53); dpy-4 
hermaphrodites for 48 hr.  The number of self-progeny was scored.  Gray lines indicate 










Figure 3.6.  TRY-5::GFP appears to be transferred in vesicles.  Males expressing TRY-
5::GFP were mated to unc-31 hermaphrodites and seminal fluid transfer was recorded.  
A) TRY-5::GFP is present within or adjacent to cells of the valve region (arrowhead) 
after the male has begun mating but before valve TRY-5::GFP begun transfer.  TRY-
5::GFP appears localized to vesicle-like structures.  B)  TRY-5::GFP in the valve region 
(arrowhead) after TRY-5::GFP transfer appears to be limited to the cells of the valve 
region in vesicle-like structures (arrows).  vas represents the location of the vas deferens. 
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RECOMBINANT EXPRESSION AND IN VIVO 
REGULATION OF TRY-5 
 
Introduction 
 Proteases are frequently found in seminal fluid (reviewed in Veveris-Lowe et al., 
2007); however, in many cases, their functions remain unknown.  Signals that increase or 
decrease sperm motility are poorly understood.  These signals may or not be dependent 
on proteolysis.  In some cases, likely signals have been identified (such as degraded 
semenogelins), but how they function is not understood (reviewed in de Lamirande, 
2007).  Recently, a likely protease, TRY-5, that signals sperm activation in 
Caenorhabditis elegans was identified; how it signals activation remains unknown 
(Smith and Stanfield, 2011).  By studying how TRY-5 can signal sperm motility in 
nematodes, conserved mechanisms for regulation of sperm motility in other organisms 
may be found.
 
Activity of TRY-5 
 Based on sequence homology, TRY-5 is predicted to be a trypsin-like serine 
protease.  However, TRY-5 has not been directly shown to have proteolytic activity.  
Even if it does have protease activity, TRY-5 may have a different substrate specificity 




allow for testing of activity, which could be assayed using two methods.  One assay 
would be a biological test of the ability of purified TRY-5 protein to activate sperm.  This 
experiment would indicate that the purified protein is active, but would not determine 
whether TRY-5 is indeed a protease.  To test if TRY-5 is a protease, a biochemical assay 
could be performed using fluorogenic peptides, which fluoresce after being cleaved, to 
test for proteolytic activity and determine whether TRY-5 shares the specificity of other 
trypsin-like serine proteases.  The specificity of TRY-5 is of interest due to one of the 
predicted substrate binding residues differing from that of other serine proteases.  This 
information could help predict the target of TRY-5 and whether it is on the sperm cell 
surface or another seminal fluid protein. 
 Genetics-based experiments have shown that try-5 is necessary for several aspects 
of sperm activation, such as the premature sperm activation phenotype observed in swm-1 
mutant males and transactivation of spe-8 mutant hermaphrodite sperm (Smith and 
Stanfield, 2011).  However, those experiments did not indicate whether or not the TRY-5 
protein functions directly on sperm, as opposed to an indirect mechanism, such as 
signaling through another protein.  If TRY-5 acts directly on sperm, it would represent a 
protease pathway that signals quick, irreversible changes to activate sperm.  If TRY-5 
acts on another portion of the pathway, then a possible signal amplifying pathway, which 
may or may not be a protease cascade, would be identified.  A cascade would indicate 
how a strong signal is produced, similar to earlier steps in platelet activation (reviewed in 
Roberts et al., 1998; Schenone et al., 2004).  The simplest test of whether TRY-5 




 The substrate specificity of TRY-5 and whether it directly signals sperm 
activation could aid in determining the downstream steps of activation.  For instance, if 
TRY-5 is known to directly signal sperm activation, then sperm surface proteins would 
be expected to be cleaved.  By knowing the substrate specificity and that TRY-5 has 
protease activity, target proteins can be predicted and assayed for cleavage by TRY-5.  
The ideal proteins would have the appropriate cleavage site, contain a transmembrane 
domain and be expressed in sperm.  However, if TRY-5 does not activate sperm, 
potential targets can be identified by assaying secreted proteins that are more highly 
expressed in males. 
 
Regulation of TRY-5 expression 
 In a swm-1 mutant background, an upregulation of TRY-5 seemed to occur as 
compared to wild-type worms.  TRY-5::GFP was present not only in the tissues of 
expression, but also in the lumen of the seminal vesicle.  The cells of the valve region and 
vas deferens appeared to contain equal or more TRY-5::GFP when compared to swm-1 
wild-type males.  A model for upregulation would be that depletion of TRY-5 from the 
cells of the somatic could be detected, and in response additional TRY-5 is produced.  
Upregulation of TRY-5 expression after mating could prepare the male for another round 
of mating.  To quantify the levels of TRY-5 in wild-type and swm-1 mutant males, 
Western blots can be performed on males that carry a stable TRY-5::GFP insertion using 
an anti-GFP antibody. 
 Exploring the biochemistry of TRY-5 will help determine how it functions in 




biochemically.  This analysis includes optimization of Western blots to detect TRY-
5::GFP and expression of TRY-5 in E. coli for purification. 
 
Results 
Comparison of TRY-5 levels in swm-1 wild-type 
and mutant males 
 In virgin adult males with the TRY-5::GFP transgene in swm-1 mutant 
backgrounds, the level of TRY-5::GFP seemed elevated (Figure 4.1).  This elevated level 
may have been due to an actual increase of TRY-5::GFP, levels thus more TRY-5::GFP 
was likely present in the animal; or due to TRY-5::GFP having a more broad localization 
creating the appearance of more TRY-5::GFP.  To differentiate between these two 
possibilities, I sought to compare protein levels between swm-1 mutant and wild-type 
animals. 
 To measure protein levels of TRY-5::GFP, I performed Western blots on virgin 
males that were aged 48 hr after the L4 stage and OP50 bacteria, which is used to feed 
worms, as a control.  I noted that many bands were present in each lane, including the 
OP50 bacteria only control and males not expressing GFP, suggesting that those bands 
are the result of nonspecific binding of the antibody to proteins present in bacteria and 
worms.  The specific-binding band was slightly above the predicted TRY-5::GFP size 
(66.5 kDa) and was visible when 50 worms were loaded.  The control GFP band was 
visible (27 kDa) when 15 mIs11[Pmyo-2::GFP, Ppes-10::GFP, gut::GFP] males were 
loaded (Figure 4.2).  To reduce nonspecific binding of the antibody, I preabsorbed the 
anti-GFP antibody with acetone powder made from bacteria or him-5 worms.  Acetone 




After preabsorption of the anti-GFP antibodies with either acetone powder, the signal was 
reduced for all bands, including both the nonspecific and specific bands (data not shown).  
However, after several rounds of optimization with nonpreabsorbed antibody, a 
consistent strong signal was visible at the expected TRY-5::GFP size (Figure 4.2). 
 To ensure that samples are properly loaded so that an equal number of worms is 
loaded into each well, I sought to optimize a potential loading control.  I tested an anti-α-
tubulin antibody (DM1α, Sigma) that has been previously used as a C. elegans loading 
control.  Using this antibody, a specific α-tubulin band can be seen near the expected size 
of 50 kDa (Figure 4.3, A. Snow).  I found the level of protein observed did not correlate 
with the number of worms loaded.  Optimization of this antibody is ongoing, after which 
the optimal conditions for stripping a blot probed with the anti-GFP antibody and then 
probing with the anti-α-tubulin antibody will be determined. 
 
Protein expression 
 To test whether TRY-5 acts directly on sperm to signal activation, TRY-5 protein 
will be purified, and whether the purified protein is sufficient for sperm activation will be 
determined.  TRY-5 is predicted to contain four disulfide bonds, based on conservation 
with other trypsin-like serine proteases.  To increase the likelihood that TRY-5 would 
fold properly and be soluble, I expressed TRY-5 from several constructs consisting of 
TRY-5 fused to different tags in two different strains of Escherichia coli.  I generated 
three constructs in expression vectors that expressed try-5 cDNA: glutathione S-
transferase fused to TRY-5 (GST-TRY-5), maltose binding protein fused to TRY-5 (Mal-
TRY-5), and a 6X His tag fused to Trigger Factor (a chaperone) fused to TRY-5 (HisTF-




expression strain, BL21 (DE3), and a strain that contains two mutations that produce an 
environment that improves formation of disulfide bonds, Origami (DE3).  Transformation 
of Origami (DE3) with Mal-TRY-5 did not occur successfully, and was subsequently not 
tested for expression of TRY-5. 
 To determine which constructs were most likely to express a high level of soluble 
protein, I induced expression in each construct-strain pair and looked for increased 
protein production by running a protein gel and staining with Coomassie blue.  I found 
strong TRY-5 expression when using the GST-TRY-5 construct in BL21 cells only and 
the HisTF-TRY-5 construct in both BL21 and Origami cells (Figure 4.5A).  I tested the 
solubility of the protein product in a buffer consisting of Tris, EDTA, salt, and glycerol, 
and found that TRY-5 produced from the HisTF-TRY-5 construct was highly soluble in 
this buffer (Figure 4.5B). 
 
Discussion 
 At this point, not enough data has been collected to make any conclusions about 
the character of the TRY-5 protein.  As observed by Western blot, TRY-5::GFP appears 
to be approximately the same size as that predicted based on cDNA sequence (Smith and 
Stanfield, 2011).  This suggests that TRY-5 is not processed in any significant way, 
whether by cleaving or some other modification.  However, any minor modifications 
would not be detected with the conditions used for the Western blot.  In addition, due to 
nonspecific binding observed with all anti-GFP antibodies tested, cleavage products of 
TRY-5 may not be detectable.  TRY-5 is the predicted length when expressed in bacteria, 




 The level of TRY-5 protein in swm-1 mutant males has not been examined at this 
point.  However, conditions have been identified that would allow for comparison of the 
amount of TRY-5 present in different genetic backgrounds.  Since conditions allow for 
clear observation of full-length TRY-5::GFP protein levels, comparison of wild-type and 
swm-1 mutants can be performed.  To ensure that proper loading occurs, a loading control 
still needs to be developed, either by continued optimization of the anti-α-tubulin 
antibody or use of a different loading control. 
 Similarly, active TRY-5 protein has not been purified at this point, but some 
conditions that may produce protein have been identified.  This includes expressing 
TRY-5 from the HisTF-TRY-5 construct in BL21 or Origami cells.  This expression 
system produces a high level of TRY-5 protein that is also soluble.  However, steps have 
not been taken yet to purify TRY-5.  When expressed from the HisTF-TRY-5 construct, 
TRY-5 would be purified using a nickel column, and then the Trigger Factor tag removed 
using a protease that targets one of the three protease recognition sites.  TRY-5 would be 
further purified either by removing the tag and protease using a nickel column, or by 
using high-performance liquid chromatography to separate the different proteins. 
 
Materials and methods 
Strains used 
 Worm strains were grown on NGM at 20°C and fed with OP50 (Brenner, 1974).  
Strains used were (described in Smith and Stanfield, 2011): jnSi62[Ptry-5::TRY-5::GFP] 
I; try-5(tm3813) him-5(e1490) V, jnSi62[Ptry-5::TRY-5::GFP] I; swm-1(me87) try-
5(tm3813) him-5(e1490) V, jnSi92[Ptry-5::TRY-5::GFP] I; try-5(tm3813) him-5(e1490) 




Ppes-10::GFP, gut::GFP] IV; him-5(e1490) V .  Bacterial strains used for protein 
expression were BL21(DE3) and Origami(DE3) (Novagen). 
 
Western blots 
 Adult virgin males (unless otherwise indicated) were picked into 2 µL of water.  
Eight µL of 1.25X SDS loading buffer (62.5 mM Tris-HCl pH 6.8, 125 mM DTT, 2.5% 
SDS, 12.5% Glycerol, 9.375 M Urea, Bromophenol Blue) were added.  While optimizing 
detection of α-tubulin, protease inhibitors (Complete ULTRA, EDTA-free, Roche) were 
added to the loading buffer.  The mixture was incubated at 98°C for 5 min, and then 
frozen on dry ice 1 hr.  Samples were then either used immediately or frozen at -80°C.  
Samples were thawed, β-mercaptoethanol was added to 10 mM, and the sample was 
incubated at 98°C for 5 min.  The samples were then briefly centrifuged and loaded on a 
10% resolving SDS-PAGE gel.  The samples were transferred to a nitrocellulose 
membrane (Hybond ECL, GE Healthcare) using a semi-dry blotter (BioRad) run at 15 V 
for 45 min.  Transfer was confirmed by Ponceau S stain (Amresco).  The membrane was 
then blocked using Blotto (5% dry milk added to TBST (20 mM Tris pH 7.4, 500 mM 
NaCl, 0.05% Tween-20)).  Probing was performed 1-3 hr at room temperature or 
overnight at 4°C using primary antibody, the membrane was rinsed with TBST and 
washed six times for 5 min each with TBST, stained with secondary for 1 hr, and the 
washes were repeated.  Then the membrane was incubate with SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Fisher).  Membranes were exposed to X-ray film 
(Amersham Hyperfilm ECL, GE Healthcare) and the film was developed.  Antibodies 
used were: anti-GFP: Living Colors GFP Monoclonal Antibody, Clontech (Catalog 




mouse, Sigma-Aldrich (Catalog number: T6199), and Blotting Grade Affinity Purified 
Goat Anti-Mouse IgG (H + L) Horseradish Conjugate, Bio-Rad (Catalog number: 170-
6516). 
 
Cloning try-5 cDNA into expression vectors 
 To express TRY-5, I cloned try-5 cDNA without the predicted signal sequence 
(the first 24 amino acids of the sequence were removed) into the various vectors using 
standard cloning techniques (see Table 4.1 for details) (Sambrook et al., 1989).  
Constructs were transformed into BL21 (DE3) and Origami (DE3) cells.  Correct 
transformation was confirmed by purifying each construct from each strain and using 
restriction digest to ensure that no large-scale modifications had occurred. 
 
Protein expression 
 Single colonies of bacteria with the TRY-5 constructs were grown in 1.5 mL LB 
starting cultures that were grown overnight at 37°C.  Subsequently, the cultures were 
diluted to an OD600 of approximately 0.2 in 2-3 mL LB and allowed to grow to an 
OD600 of 0.5.  0.5 mM IPTG was added to the GST-TRY-5 and Mal-TRY-5 cultures, 
and the cells allowed to express for 5 hr at 37°C.  For the HisTF-TRY-5 construct, once 
an OD600 of 0.5 was reached, the cells were placed in a shaking water bath set at 16°C 
for 30 min before adding 0.5 mM IPTG and the cells were then allowed to express TRY-
5 for 24 hr at 16°C.  After the expression period, a 0.5 mL sample was taken, centrifuged, 
and the supernatant was removed and saved.  The remainder of the culture was also 
centrifuged and the supernatant discarded.  To determine expression levels, the 0.5 mL 




SDS, 10% β-mercaptoethanol, 30% glycerol, 8 M urea) and 15 µL was run on an SDS-
PAGE gel.  To ensure that cells were not releasing TRY-5 into the media, the media was 
also run on the gel.  In cases in which expression was seen, the remaining pellet was 
resuspended in Buffer A (50 mM Tris-HCl pH 8.0, 0.5 mM EDTA, 50 mM NaCl, 5% 
glycerol) and sonicated using a sonication cup (10 min, 50% duty cycle, power level 0.7).  
The resulting solution was centrifuged 10 min, 4°C and the supernatant removed and 
saved.  The pellet was resuspended in Buffer A (pH 8.0) plus 1% Triton X-100 (Sigma) 
and incubated on ice for 10 min, then centrifuged 10 min at 4°C, and the supernatant 
removed and saved. 
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Figure 4.1.  TRY-5 expression appears to be increased in swm-1 mutant males.  
jnSi62[Ptry-5::TRY-5::GFP]; try-5(tm3813) males were examined for levels of GFP 
within the male.  Within the seminal vesicle, swm-1(me87) males had additional TRY-









Figure 4.2.  Western blot of TRY-5::GFP expressing worms.  Worms were probed for 
GFP expression.  In each lane 50 adult males were loaded, except for the mIs11[GFP] 
lane, in which 15 adult male worms were loaded.  TRY-5::GFP has a predicted size of 
66.5 kDa.  GFP expressed in mIs11 worms is predicted to be 27 kDa.  Asterisks indicate 
the predicted specific band based on absence from lanes not expressing GFP.  1:10000 
anti-GFP (Clontech) was used as the primary and 1:2000 chicken anti-mouse HRP 










Figure 4.3.  Western blot of α-tubulin.  In each lane 50 adult males were loaded, except 
for the mIs11[GFP] lane, in which 15 worms were loaded.  Protease inhibitors were 
added prior to lysis, as indicated.  α-tubulin has a predicted size of 50 kDa.  1:500 anti-α-
tubulin antibody (DM1α, Sigma) was used for the primary and 1:1000 chicken anti-















Figure 4.4.  TRY-5 fusion proteins.  Fusions that were made are: a 6X His tag::Trigger 
Factor::TRY-5 fusion (HisTF-TRY-5), a maltose binding protein::TRY-5 fusion (Mal-
TRY-5), and a glutathione S-transferase::TRY-5 fusion (GST-TRY-5).  The multiple 
protease cleavage sites region contains cleavage sites for HRV 3C protease, thrombin, 







Figure 4.5.  Expression and solubility of TRY-5 protein expressed in E. coli.  A) 
Expression of TRY-5 in E. coli.  TRY-5 was expressed in both BL21 and Origami cells 
in three different vectors.  Protein was run on a 10% SDS-PAGE gel.  Three samples 
were run for each condition: pelleted bacteria in which expression was not induced (U), 
media (M) and pellet (P) from bacteria that were induced with 0.5 mM IPTG.  A similar 
amount of bacteria was run in each lane.  Predicted band sizes are indicated with an 
asterisk.  Predicted sizes are GST-TRY-5: 61.7 kDa, Mal-TRY-5: 80.8 kDa, HisTF-TRY-
5: 86.8 kDa.  B) Solubility of highly expressed TRY-5.  Bacteria were sonicated to 
release expressed protein.  Lanes are bacteria prior to sonication (R) and after sonication 
(So), the supernatant after centrifugation (Sn), supernatant after resuspending pellet in 
Buffer A plus 1% Triton X-100 and centrifuging (Sd), and the resultant pellet (P).  
Asterisks indicate the predicted band size.  GST-TRY-5 did not appear soluble, while 













Table 4.1.  Protein expression constructs and their construction. 
 
Plasmid Description Length Vector Construction  
GST-TRY-5 Glutathione S-transferase fusion 
with try-5 cDNA 
5906 bp B337
1 
cDNA amplification primers  
    Fwd: GGCCGGATCCAatgatgaattgtgcggtcg  
    Rev: CCGGGCTCGAGGTaagcttgattaataaaattcacg  
    Ligated the 918 bp BamHI-XhoI fragment from cDNA 
 into the 4988 bp BamHI-XhoI fragment from B337 
 




Ligated the 910 bp BamHI-HindIII fragment from GST-TRY-5 
 into the 6601 bp BamHI-HindIII fragment from B332 
 
HisTF-TRY-5 6X His tag Trigger Factor fusion 
with try-5 cDNA 
6667 bp pColdTF Ligated the 910 bp BamHI-HindIII fragment from GST-TRY-5 











Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71-94. 
de Lamirande, E. (2007). Semenogelin, the main protein of the human semen coagulum, 
regulates sperm function. Semin Thromb Hemost 33, 60-68. 
Roberts, H.R., Monroe, D.M., Oliver, J.A., Chang, J.Y., and Hoffman, M. (1998). Newer 
concepts of blood coagulation. Haemophilia 4, 331-334. 
Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory 
Manual (Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press). 
Schenone, M., Furie, B.C., and Furie, B. (2004). The blood coagulation cascade. Curr 
Opin Hematol 11, 272-277. 
Smith, J.R., and Stanfield, G.M. (2011). TRY-5 is a sperm-activating protease in 
Caenorhabditis elegans seminal fluid. PLoS Genet 7, e1002375. 
Veveris-Lowe, T.L., Kruger, S.J., Walsh, T., Gardiner, R.A., and Clements, J.A. (2007). 
Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related 








SUMMARY, FUTURE DIRECTIONS, AND CONCLUSIONS 
 
Summary 
 Sperm activation in C. elegans has presented an opportunity to study a system for 
the rapid acquisition of motility in cells and mechanisms for regulation of sperm motility.  
try-5 has been identified as necessary for sperm motility to occur in swm-1 mutant males.  
Before this study, the activation signal in both the hermaphrodite sperm activation and 
male sperm activation pathways were unidentified.  TRY-5 represents an activation 
signal in the male sperm activation pathway. 
 Efforts to identify the sperm activation pathway within males were made difficult 
by activation not occurring until after mating.  In addition, the hermaphrodite sperm 
activation signal is likely able to activate male sperm, thus screening for infertile males 
would not have identified the signal.  The identification of swm-1 (Stanfield and 
Villeneuve, 2006) as necessary for the inhibition of sperm activation within males 
allowed for a simplified screen for activation signals in males, since sperm activation 
could be scored within virgin males.  Such screens have identified try-5 and other genes 
necessary for sperm activation.
 In vitro studies have found that proteases can activate sperm, suggesting that such 
a mechanism might also activate sperm in vivo.  This model was supported by the 
identification of swm-1, which encodes a protein with two trypsin inhibitor-like (TIL) 
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domains (Stanfield and Villeneuve, 2006).  The role of proteases in sperm activation is 
further supported by the identification of try-5 as necessary for the premature sperm 
activation seen in swm-1 males.  However, at this point, whether TRY-5 has protease 
activity and what the targets of TRY-5 are remains unknown.  Genes necessary for 
protease-dependent sperm activation may have been identified in the swm-1 suppression 
screen (A. Hansen, G. Stanfield, personal communication). 
 Protease signaling is conserved in multiple organisms.  Protease signaling is 
required for blood clot formation after injury.  Frequently, a pathway involves multiple 
proteases that amplify the signal.  Protease cascades are involved in coagulation 
(reviewed in (Maas et al., 2011)) and recently have been found to function in Drosophila 
seminal fluid to signal multiple postmating female responses (LaFlamme et al., 2012).  
Protease cascades have been hypothesized to have roles in male fertility (Yousef and 
Diamandis, 2001); however, no evidence for such function exists.  Protease cascades 
have not been identified in mammalian seminal fluid, but proteases have been found to 
function in regulating sperm motility.  The most well characterized protein is prostate 
specific antigen (PSA).  After mating, a seminal clot forms that restricts sperm 
movement.  PSA dissolves the clot by cleaving the proteins that form it, allowing sperm 
to become motile again (Christensson et al., 1990).  The cleavage products are also 
thought to have antimicrobial properties (Bourgeon et al., 2004).  TRY-5 represents 
another protease signal that has a clear function in sperm activation.  Sperm activation is 
a significant morphological change, and by using activation as an indication of signaling, 
TRY-5 may be useful for studying how proteases signal quick, irreversible responses and 
how the protease activity can be regulated. 
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 TRY-5 appeared to not only have activity in signaling male sperm activation, but 
also in signaling activation of spe-8 mutant hermaphrodite sperm.  Since the discovery of 
spe-8, two separate sperm activation pathways have been hypothesized: a male pathway 
and a hermaphrodite pathway.  Hermaphrodite spe-8 group mutants are infertile, since 
their sperm are not able to activate.  spe-8 group mutant males are fertile.  In addition, 
these male retain the ability to activate spe-8 group mutant hermaphrodite sperm.  These 
results suggested that male worms likely contain an activator in their seminal fluid that is 
independent of the hermaphrodite sperm activator.  In vitro activation studies showed that 
proteases were not able to fully activate the spe-8 mutant sperm; instead, spikes formed.  
These spikes are likely not due to the conditions used, since spe-8; swm-1 mutant males 
also contain spiky sperm.  These results suggest that the spe-8 group may be necessary 
even in male sperm activation.  Formation of spikes may be the result of reduced activity.  
I found that TRY-5 is necessary for transactivation of spe-8 mutant hermaphrodite sperm, 
which suggests that TRY-5 is either the sperm activation signal or upstream of the 
activation signal.  I confirmed that TRY-5 is necessary for the activation of spe-8 mutant 
sperm by examining spe-8 group; try-5 animals.  I found that these worms were 
completely infertile, including after mating, which shows that all paths to sperm 
activation have been blocked.  The differences between hermaphrodite and male spe-8 
sperm activation suggest that male and hermaphrodite sperm may contain different gene 
products. The only confirmed difference between male and hermaphrodite sperm is size.  
However, eight genes that may be male-sperm specific have been identified using 
microarray of males and hermaphrodites with and without germlines (Reinke et al., 
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2004).  Whether these genes indeed function only in the male has not been confirmed.  
The differences in activation may only be due to extracellular signals. 
 To determine whether TRY-5 could be directly responsible for sperm activation, I 
examined TRY-5::GFP fusion-expressing males.  I found that only males express TRY-5 
in the somatic gonad.  The fusion protein in virgin adult males localized to the vas 
deferens (a known seminal fluid contributor) and the valve region (a poorly understood 
region that is thought to regulate the release of sperm).  In a few cases, I found TRY-
5::GFP within the lumen of the seminal vesicle, surrounding sperm.  In these cases sperm 
tended to be activated.  This observation suggests that TRY-5 could act as a signal for 
sperm activation.  This model is supported by swm-1 mutants, in which TRY-5::GFP fills 
the lumen, surrounding activated sperm. 
 To be directly responsible for signaling activation of spe-8 mutant hermaphrodite 
sperm, TRY-5 would have to be transferred.  I do indeed observe transfer during mating.  
TRY-5::GFP represents the first marker of seminal fluid transfer.  I performed some 
initial characterization of seminal fluid transfer and found that seminal fluid transfer 
occurred in an ordered process.  First, TRY-5 from the vas deferens was transferred, 
which was followed by a brief pause, before valve TRY-5::GFP was transferred, 
immediately followed by sperm transfer.  Upon further examination, transfer appeared to 
occur in small vesicles that are released from the valve region.  Whether release of TRY-
5 from the vas deferens occurs in vesicles is unknown.  Currently, the localization of 
SWM-1 is unknown, thus the interactions that occur between SWM-1 and TRY-5 during 
the storage and transfer of sperm remain unknown. 
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 While investigating the localization of TRY-5::GFP, I attempted to rescue TRY-5 
activity in specific tissues.  I found that expression in neurons still resulted in sperm 
activation in swm-1 mutant males.  Proteases may be able to cleave proteins that seal the 
lumen of the somatic gonad, thus TRY-5 may be able to enter the somatic gonad when 
expressed anywhere in the worm.  In some cases, worms that were overexpressing TRY-
5 appeared very unhealthy, sometimes with tissues disconnecting from others (data not 
shown), supporting that TRY-5, when expressed outside of the somatic gonad, may cause 
tissue damage that allows for openings into the somatic gonad.  Whether TRY-5 may 
damage hermaphrodite tissue after mating has not been determined.  Hermaphrodites may 
or may not have reduced lifespan after mating.  Van Voorhies (1992) found that lifespan 
was reduced in males, but not hermaphrodites, after mating.  Gems and Riddle (1996) 
found that lifespan was reduced in mated hermaphrodites, and that this reduction was 
independent of production of progeny and reception of sperm from males.  That result 
suggests that any lifespan reduction would be due to something within the seminal fluid.  
TRY-5 could be responsible for reduction of lifespan.  If a protease is responsible for 
decreased lifespan, then hermaphrodites may have evolved a protective mechanism 
against damage. 
 These results have led to a model where TRY-5 is the seminal fluid male sperm 
activation signal.  Before mating, TRY-5 is stored in the tissues of the somatic gonad, and 
any prematurely released TRY-5 is inhibited by SWM-1.  During mating, TRY-5 is 
transferred in discrete steps.  TRY-5 activates sperm, either during transfer or once in the 
hermaphrodite.  If a male mates with a spe-8 mutant hermaphrodite, the transferred TRY-
5 is able to signal hermaphrodite sperm activation. 
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 Despite acting as a sperm activation signal, try-5 is not necessary for male 
fertility.  If try-5 is not necessary for fertility, then try-5 must be maintained for some 
other reason.  One possibility is that the hermaphrodite sperm activation mechanism 
evolved recently, and thus try-5 has not been selected against.  This hypothesis is unlikely 
since hermaphrodites evolved 20-50 million years ago (Cutter, 2008); selection against 
try-5 should have been possible over such a time period.  Alternatively, try-5 has some 
other role that our experiments have not been able to detect.  try-5 may have subtle roles 
in ensuring fertility when mated to wild-type hermaphrodites.  Two nonexclusive models 
for how try-5 may improve male fertility are possible.  TRY-5 protein may ensure timely 
male sperm activation.  Also, TRY-5 may damage sperm present in the hermaphrodite 
improving competition.  Experiments testing these models are ongoing. 
 Furthermore, evidence for a function of proteases in sperm activation has been 
found in Ascaris suum.  A serine protease inhibitor, As_SRP-1, was identified that is 
necessary for maintenance of sperm activation.  As_SRP-1 binds to a serine protease, 
which was named As_TRY-5.  A partially purified male gonad extract that contained 
As_TRY-5 was capable of sperm activation, except when As_SRP-1 was added, which 
suggests that in Ascaris a protease is also responsible for sperm activation.  These results 
suggest that protease activation of sperm is conserved in nematodes. 
 
Future work 
 I have primarily examined how try-5 functions in sperm activation using 
mutations in the try-5 gene and transgenes expressing try-5.  My results support a model 
in which the TRY-5 protein signals sperm activation; however, whether this interaction is 
direct has not been tested.  To show whether TRY-5 directly signals sperm activation 
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requires biochemical techniques.  To determine whether TRY-5 directly acts on sperm to 
signal activation, purified TRY-5 can be added to sperm in vitro.  If sperm activate in the 
presence of TRY-5, then it likely acts directly on sperm.  An activation curve testing the 
level of activation with different concentrations of TRY-5 would indicate whether TRY-5 
could activate under physiological conditions.  If TRY-5 does not signal activation, then 
TRY-5 may act indirectly to activate sperm.  For instance, TRY-5 may signal through a 
protease cascade or further upstream in the process of sperm activation.  Alternatively, 
TRY-5 may be necessary for the secretion of the activator.  In either case, the function of 
TRY-5 would need to be confirmed, including testing if TRY-5 is a protease.  Such a 
function could be shown by testing a library of fluorogenic peptides for cleavage.  
Sequence specificity could be determined using this library.  The specificity of TRY-5 
could give clues in identifying the likely target of TRY-5 function, by searching for 
sperm-expressed, membrane-bound proteins that have the specificity sequence in that 
protein’s extracellular domain. 
 The sperm components that receive the activation signal have yet to be identified; 
however, identification of candidates is ongoing, based on genes identified in swm-1 
suppressor screens that are necessary for the premature sperm activation phenotype.  If 
TRY-5 does signal sperm activation directly, then these candidates should be cleaved in a 
swm-1 mutant background.  Furthermore, suppression of this cleavage should occur in a 
swm-1 try-5 mutant background.  In addition, direct activation of sperm by TRY-5 would 
allow testing of cleavage in isolated sperm in vitro.  While additional extracellular 
signaling components may exist upstream of SWM-1 and TRY-5, identifying a direct 
interaction between TRY-5 and a sperm membrane component that signals activation 
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would suggest that TRY-5 is the direct sperm activator.  Thus, all proteins that function 
between TRY-5 and the receptor would have been identified, except for redundant 
signals.  Redundant signals likely are not present since mutations in the spe-8 group and 
try-5 eliminate all forms of activation. 
 Sperm activate in vitro when exposed to a mixture of proteases called Pronase 
(Shakes and Ward, 1989); however, the activated sperm are not capable of fertilization.  
Two models exist for how this ability is lost.  Pronase might cleave proteins that are 
necessary for fertilization that normally would not be cleaved by TRY-5.  Certain 
proteins necessary for fertilization are only on the surface of sperm after activation (Xu 
and Sternberg, 2003).  These and other proteins necessary for sperm competition may be 
cleaved by both Pronase and TRY-5.  In the first case, Pronase contains multiple 
proteases, thus it likely cleaves many different proteins, and Pronase may cause damage 
to sperm that TRY-5 while the endogenous protease signal would not.  Alternatively, 
TRY-5 or the protease signal may cleave the same proteins.  This translocation may 
occur as a result of the membranous organelles fusing to the sperm surface during 
activation.  Such a model is supported by the translocation of SPE-41 during sperm 
activation (Xu and Sternberg, 2003).  In such a case, TRY-5 may be exposed to sperm 
during a short period after which it diffuses to a low concentration, is removed from the 
hermaphrodite, or is degraded.  This short period could be sufficient to activate sperm, 
and the protease could be removed prior to exposure of the fertilization components.  I 
have observed that as males terminate mating, some TRY-5 frequently leaves the uterus 
as the male removes its spicules.  This model would be supported if sperm activated in 
vitro by TRY-5 were not capable of fertilization unless exposure occurred for a brief 
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period of time.  Much TRY-5 remains in the uterus, thus for this model to be likely TRY-
5 would have to be quickly degraded or inhibited.  TRY-5 may represent a possible 
mechanism for sperm competition.  Sperm already activated in the hermaphrodite could 
be damaged by the transfer of TRY-5.  Sperm being transferred from the male would be 
undergoing the initial steps of activation, so might not be damaged and would be able to 
outcompete the pre-existing sperm. 
 TRY-5::GFP represents the first fluorescent marker of seminal fluid transfer in 
worms.  Being the first marker, the discovery of TRY-5 allows for many additional 
experiments that were not previously possible.  For instance, using this marker, 
identification of additional seminal fluid components could be aided by using TRY-5 as a 
control for successful mating and transfer of seminal fluid.  Identification of other 
seminal fluid proteins may be possible using mass spectroscopy based techniques.  One 
possibility would be to mark males using the 
15
N isotope, mate those males to 
hermaphrodites, and compare proteins in mated hermaphrodites to unmated 
hermaphrodites (Findlay et al., 2008).  In this case, TRY-5 would serve as a control to 
ensure that seminal fluid proteins were detected. 
 While aspects of how seminal fluid transfer is accomplished have been studied 
using TRY-5::GFP, many other aspects of seminal fluid transfer are not understood.  For 
example, mating is coupled to secretion, such that secretion occurs shortly before sperm 
transfer.  This process is not understood at several levels, including what cells and 
molecules are involved.  One possibility is that neurons coordinate the secretion and 
sperm release processes, and molecules involved in synaptic vesicle fusion to the 
membrane could be involved in the process of secretion.  Better characterization of this 
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process would also aid in analysis of secretion.  In my experiments, I was limited by the 
resolution of the microscope I was using and the light necessary for fluorescence 
interfering with mating.  Improving on the techniques used to monitor mating and using 
improved microscopy techniques may allow for higher resolution images of mating and 
shorter exposure times, increasing time resolution.  Better imaging could allow for 
observation of events that lead to secretion. 
 An interesting phenotype was observed with jn21 males.  Some swm-1(me66) try-
5(jn21) males contained activated sperm, which suggests that jn21 is a hypomorphic 
allele of try-5.  However, transactivation was completely eliminated.  Such a result 
suggests that functional TRY-5 is produced, but secretion may not occur as in the wild 
type.  By generating a TRY-5::GFP construct with this mutation, the localization of the 
mutant protein could be determined.  A differing localization during mating could 
suggest the function of the secretion signal.  The mRNA produced by this mutant could 
also indicate where translation begins and whether alternate splicing occurs.  Alternate 
splicing is a possibility, since the next translational start site is after the cysteine that is 
mutated in the jn2 allele.  Since jn2 appears to be a functional null, this cysteine might be 
critical for proper protein folding. 
 In some strains of C. elegans, a plug is deposited over the vulva during mating.  
The plug is formed by the protein PLG-1 and is thought to decrease the likelihood that 
the hermaphrodite mates with other males (Palopoli et al., 2008).  Study of TRY-5 
function may reveal additional functions for plugging.  PLG-1 is likely secreted from the 
vas deferens, from a subset of the same cells that TRY-5 is expressed in.  Whether TRY-
5 and PLG-1 are transferred simultaneously is unknown.  If TRY-5 is transferred with 
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PLG-1, then that pool of TRY-5 may be trapped in the plug or may help with its 
formation.  Additionally, the vas deferens pool of TRY-5 is transferred prior to sperm.  If 
PLG-1 is transferred simultaneously, then sperm must pass through the forming plug.  
Transfer in such a way would ensure quick plug formation behind sperm.  If a plug does 
form quickly, then TRY-5 dynamics in the hermaphrodite may be changed by the plug, 
such as increasing the time TRY-5 is in the hermaphrodite.  In my movies without 
plugging I saw that a significant amount of TRY-5 was pulled out of the hermaphrodite 
as the male removed his spicules.  A plug may cause TRY-5 to remain in the 
hermaphrodite, allowing extra time for sperm activation. 
 Despite the function of TRY-5 in sperm activation, try-5 was not required for 
male fertility in matings to spe-8 mutant hermaphrodites.  A function that is selectable 
would be necessary for maintenance of try-5.  One possibility is that try-5 is necessary for 
competition again hermaphrodite sperm.  try-5 mutant males would have lower fertility 
or a lower percentage of cross progeny when mated to wild-type hermaphrodites.  To 
reach a further understanding of how try-5 functions, examining related Caenorhabditis 
species that have try-5 may reveal a more significant role in fertility, especially in 
gonochoristic species.  In male-female species, try-5 may act as the only signal for 
activation or may have roles in male-male competition.  Thus, mutants or try-5 
knockdown in the animals would reduce male fertility, resulting in a strong selection for 
males that express try-5. 
 
Conclusions 
 I have shown that a protease is a signal for sperm activation in C. elegans.  
Protease signaling in worm fertility has been hypothesized since the discovery that 
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Pronase activates sperm in vitro.  TRY-5 likely is that protease signal.  In addition, TRY-
5 represents that first marker of seminal fluid transfer.  Previously, a seminal fluid 
component, PLG-1, had been identified, but transfer was not directly observed (Palopoli 
et al., 2008).  Thus, TRY-5 allows for studying of the process of seminal fluid transfer to 
better characterize mating. 
 This study has led to a model of sperm activation in which TRY-5 is expressed 
and stored in the somatic gonad, specifically the valve region and the vas deferens.  Any 
secreted TRY-5 is inhibited by SWM-1.  During mating TRY-5 is released from the 
somatic gonad and transferred with sperm to the hermaphrodite.  During transfer or 
shortly after entry into the hermaphrodite, the male sperm activates.  TRY-5 is also 
transferred into the hermaphrodite, since spe-8 mutant hermaphrodite sperm activate after 
mating.  This process of sperm activation is partially redundant with the hermaphrodite 
activation pathway, which remains poorly understood.  Intracellular sperm activation 
signals have been found, including the spe-8 group, which is necessary for hermaphrodite 
sperm activation to occur.  However, spe-8 sperm are competent for activation, since 
males are able to transactivate sperm.  Males may be partially dependent on the spe-8 
group, since males are less able to transactivate hermaphrodite with stronger mutant 
alleles of spe-8. 
 Proteases have been shown to have important roles in signaling.  One example is 
with blood clotting.  In clotting, a protease-activated receptor, similar to G-protein 
coupled receptors, is responsible for receiving the protease signal (reviewed in 
(Ossovskaya and Bunnett, 2004)).  The downstream signal of protease activation in 
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nematode sperm remains unknown, but identification of a different class of receptor may 
suggest other mechanisms for protease signaling. 
 Proteases also have roles in human fertility, and many different proteases are 
found in seminal fluid.  The function of many of the proteases remains unidentified, with 
the exception of PSA.  Further characterization of the male sperm activation pathway in 
nematodes may suggest parallels that exist between nematode and human sperm 
activation, which could also suggest ways to regulate protease activity in human seminal 
fluid.  Such an understanding may aid in treatment of male infertility. 
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